D. Cohen

发表

Routine upstream initiation vs deferred selective use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: the ACUITY Timing trial.

J. Ware, S. Pocock, H. White, 2007, JAMA.

Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial.

E. Topol, W. Desmet, P. D. de Feyter, 2003, JAMA.

Bioprosthetic valve fracture: Technical insights from a multicenter study.

D. Dvir, J. Webb, B. Whisenant, 2019, The Journal of thoracic and cardiovascular surgery.

Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients.

M. Mack, E. Tuzcu, L. Svensson, 2016, The New England journal of medicine.

Percutaneous treatment of protected and unprotected left main coronary stenoses with new devices: immediate angiographic results and intermediate-term follow-up.

D. Baim, D. Cohen, K. Ho, 1997, Journal of the American College of Cardiology.

One-Year Costs in Patients With a History of or at Risk for Atherothrombosis in the United States

Deepak L. Bhatt, Deepak L Bhatt, David J Cohen, 2008, Circulation. Cardiovascular quality and outcomes.

Staging classification of aortic stenosis based on the extent of cardiac damage

M. Mack, E. Tuzcu, L. Svensson, 2017, European heart journal.

Quality of life after PCI with drug-eluting stents or coronary-artery bypass surgery.

P. Serruys, F. Mohr, C. Macaya, 2011, The New England journal of medicine.

Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions

P. Serruys, M. Krucoff, S. Windecker, 2007, Circulation.

Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke.

H. Diener, W. Hacke, R. Jahan, 2015, The New England journal of medicine.

Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document.

M. Mack, P. Serruys, A. Kirtane, 2012, The Journal of thoracic and cardiovascular surgery.

Safety and efficacy of GABAA α5 antagonist S44819 in patients with ischaemic stroke: a multicentre, double-blind, randomised, placebo-controlled trial

H. Diener, C. Molina, H. Chabriat, 2020, The Lancet Neurology.

Bleeding and Ischemic Outcomes With Ticagrelor Monotherapy According to Body Mass Index.

Samin K. Sharma, P. Dehghani, T. Henry, 2022, JACC. Cardiovascular interventions.

Temporal Changes in Coronary Revascularization Procedures, Outcomes, and Costs in the Bare-Metal Stent and Drug-Eluting Stent Eras: Results From the US Medicare Program

D. Cohen, J. Ryan, L. Engelhart, 2009, Circulation.

Mechanical debulking versus balloon angioplasty for the treatment of diffuse in-stent restenosis.

H. Dauerman, D. Baim, D. Cohen, 1998, The American journal of cardiology.

Repeat Revascularization After Contemporary Percutaneous Coronary Intervention: An Evaluation of Staged, Target Lesion, and Other Unplanned Revascularization Procedures During the First Year

Michael J Pencina, Laura Mauri, David J Cohen, 2012, Circulation. Cardiovascular interventions.

L. Svensson, M. Leon, S. Kapadia, 2011, Circulation.

Predicting the Restenosis Benefit of Drug-Eluting Versus Bare Metal Stents in Percutaneous Coronary Intervention

S. Normand, J. Spertus, L. Mauri, 2011, Circulation.

Clinical restenosis after coronary stenting: perspectives from multicenter clinical trials.

D. Baim, J. Popma, D. Cohen, 2002, Journal of the American College of Cardiology.

Palmaz-Schatz stenting for treatment of focal vein graft stenosis: immediate results and long-term outcome.

D. Baim, D. Cohen, M. Moscucci, 1994, Journal of the American College of Cardiology.

Stent Thrombosis in the Modern Era: A Pooled Analysis of Multicenter Coronary Stent Clinical Trials

D. Baim, A. Lansky, J. Popma, 2001, Circulation.

Multivessel drug‐eluting stenting and impact of diabetes mellitus—A report from the EVENT registry

M. Pencina, V. Novack, N. Kleiman, 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Design of the Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel disease (FREEDOM) Trial.

V. Fuster, M. Domanski, G. Dangas, 2008, American heart journal.

Cost-Effectiveness of Prasugrel Versus Clopidogrel in Patients With Acute Coronary Syndromes and Planned Percutaneous Coronary Intervention: Results From the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel–Thrombolysis in Myocardial Infarction TRI

Irina Proskorovsky, David J. Cohen, Elizabeth M. Mahoney, 2010, Circulation.

Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial.

E. Topol, W. Desmet, P. D. de Feyter, 2004, JAMA.

Impact of calcification on percutaneous coronary intervention: MACE‐Trial 1‐year results

Manesh R. Patel, Samin K. Sharma, R. Mehran, 2019, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Rotational atherectomy for the treatment of restenotic ostial side branches jailed by prior stent placement.

H. Dauerman, D. Baim, R. Kuntz, 1998, Catheterization and cardiovascular diagnosis.

Differential mortality risk of postprocedural creatine kinase-MB elevation following successful versus unsuccessful stent procedures.

A. Jeremias, D. Baim, J. Popma, 2004, Journal of the American College of Cardiology.

Effect of glycoprotein IIb/IIIa receptor inhibition on angiographic complications during percutaneous coronary intervention in the ESPRIT trial.

J. Tcheng, D. Cohen, J. Blankenship, 2001, Journal of the American College of Cardiology.

Mortality Risk of Postprocedural reatine Kinase-MB Elevation Following uccessful Versus Unsuccessful Stent Procedures

D. Baim, D. Cohen, D. Cutlip, 2016 .

Elevation of the creatine kinase myocardial isoform following otherwise successful directional coronary atherectomy and stenting.

D. Baim, D. Cohen, M. Moscucci, 1994, The American journal of cardiology.

The Effect and Relationship of Frailty Indices on Survival After Transcatheter Aortic Valve Replacement.

M. Mack, A. Kirtane, A. Kosinski, 2020, JACC. Cardiovascular interventions.

Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document.

Pascal Vranckx, Susheel Kodali, Patrick W Serruys, 2012, Journal of the American College of Cardiology.

In-hospital switching between adenosine diphosphate receptor inhibitors in patients with acute myocardial infarction treated with percutaneous coronary intervention: Insights into contemporary practice from the TRANSLATE-ACS study

K. Anstrom, J. Messenger, A. Bagai, 2015, European heart journal. Acute cardiovascular care.

Long-term efficacy of platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention.

R. Califf, C. Buller, W. Cantor, 2002, JAMA.

Multivessel Palmaz-Schatz stenting: early results and one-year outcome.

D. Baim, D. Cohen, K. Ho, 1997, Journal of the American College of Cardiology.

Development and Application of a Risk Prediction Model for In-Hospital Stroke After Transcatheter Aortic Valve Replacement: A Report From The Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry.

Sean M. O'Brien, J. Carroll, M. Mack, 2019, The Annals of thoracic surgery.

Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis

J. Leipsic, M. Mack, N. Weissman, 2016, The Lancet.

Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document.

M. Mack, P. Serruys, A. Kirtane, 2012, Journal of the American College of Cardiology.

Vascular closure devices: the second decade.

H. Dauerman, D. Cohen, R. Applegate, 2007, Journal of the American College of Cardiology.

Beyond Restenosis: Five-Year Clinical Outcomes From Second-Generation Coronary Stent Trials

D. Baim, J. Massaro, D. Cohen, 2004, Circulation.

Bivalirudin versus heparin and glycoprotein IIb/IIIa inhibition among patients with renal impairment undergoing percutaneous coronary intervention (a subanalysis of the REPLACE-2 trial).

E. Topol, T. Henry, A. Lincoff, 2005, The American journal of cardiology.

The impact of bivalirudin on percutaneous coronary intervention-related bleeding.

E. Mahoney, D. Cohen, K. Kennedy, 2010 .

Mechanisms of restenosis and redilation within coronary stents--quantitative angiographic assessment.

D. Baim, D. Cohen, C. Gibson, 1993, Journal of the American College of Cardiology.

Is 40% to 70% diameter narrowing at the site of previous stenting or directional coronary atherectomy clinically significant?

D. Baim, D. Cohen, C. Gibson, 1994, The American journal of cardiology.

Balloon postdilation can safely improve the results of successful (but suboptimal) directional coronary atherectomy.

D. Baim, D. Cohen, R. Kuntz, 1993, The American journal of cardiology.

Clinical and Economic Outcomes of Percutaneous Coronary Interventions in the Elderly: An Analysis of Medicare Claims Data

D. Cohen, M. Lacey, M. Clark, 2004, Circulation.

Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents.

J. Granada, M. Parikh, N. Kleiman, 2007, JAMA.

Optimum percutaneous transluminal coronary angioplasty compared with routine stent strategy trial (OPUS-1): a randomised trial

J. J. Griffin, V. L. Clark, W. Weaver, 2000, The Lancet.

Economic assessment of rheolytic thrombectomy versus intracoronary urokinase for treatment of extensive intracoronary thrombus: Results from a randomized clinical trial.

D. Baim, D. Cohen, D. Cutlip, 2001, American heart journal.

Valve Academic Research Consortium 3: updated endpoint definitions for aortic valve clinical research.

J. Leipsic, M. Mack, T. Nazif, 2021, European heart journal.

Valve Academic Research Consortium 3: Updated Endpoint Definitions for Aortic Valve Clinical Research.

Jeroen J. Bax, J. Leipsic, M. Mack, 2021, Journal of the American College of Cardiology.

Outcomes 2 Years After Transcatheter Aortic Valve Replacement in Patients at Low Surgical Risk.

J. Leipsic, M. Mack, M. Leon, 2021, Journal of the American College of Cardiology.

Transcatheter Aortic‐Valve Replacement with a Balloon‐Expandable Valve in Low‐Risk Patients

J. Leipsic, S. Pocock, M. Mack, 2019, The New England journal of medicine.

Stroke After Surgical Versus Transfemoral Transcatheter Aortic Valve Replacement in the PARTNER Trial.

M. Mack, E. Tuzcu, L. Svensson, 2018, Journal of the American College of Cardiology.

Prevalence, Predictors, and Outcomes of Premature Discontinuation of Thienopyridine Therapy After Drug-Eluting Stent Placement: Results From the PREMIER Registry

Harlan M. Krumholz, John C. Messenger, Richard G. Bach, 2006, Circulation.

Stent Thrombosis After Successful Sirolimus-Eluting Stent Implantation

David J Cohen, Brett G. Sylvia, A. Jeremias, 2004, Circulation.

Rotational atherectomy or balloon angioplasty in the treatment of intra‐stent restenosis: BARASTER Multicenter Registry

P. Teirstein, S. Goldberg, H. Dauerman, 2000, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

ST-segment elevation myocardial infarction

Hugo A. Katus, Hiroki Shiomi, Birgit Vogel, 2019, Nature Reviews Disease Primers.

Cost-effectiveness of sirolimus-eluting stents compared with vascular brachytherapy for the treatment of in-stent restenosis.

D. Holmes, D. Cohen, M. Reynolds, 2007, American heart journal.

Effect of SAPIEN 3 Transcatheter Valve Implantation on Health Status in Patients With Severe Aortic Stenosis at Intermediate Surgical Risk: Results From the PARTNER S3i Trial.

E. Tuzcu, M. Leon, D. C. Miller, 2018, JACC. Cardiovascular interventions.

Cardiac Damage and Quality of Life After Aortic Valve Replacement in the PARTNER Trials.

Jeroen J. Bax, T. Nazif, M. Leon, 2023, Journal of the American College of Cardiology.

Impact of Frailty and Prefrailty on Outcomes of Transcatheter or Surgical Aortic Valve Replacement

M. Mack, M. Leon, Craig R. Smith, 2022, Circulation. Cardiovascular interventions.

Very early changes in quality of life after transcatheter aortic valve replacement: Results from the 3M TAVR trial.

D. Wood, S. Lauck, J. Webb, 2020, Cardiovascular revascularization medicine : including molecular interventions.

Impact of Short-Term Complications of TAVR on Longer-Term Outcomes: Results from the STS/ACC Transcatheter Valve Therapy Registry.

J. Carroll, M. Mack, J. Bavaria, 2020, European heart journal. Quality of care & clinical outcomes.

Health Status Benefits of Transcatheter vs Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Intermediate Surgical Risk: Results From the PARTNER 2 Randomized Clinical Trial

M. Mack, L. Svensson, M. Leon, 2017, JAMA cardiology.

Health Status After Transcatheter or Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Increased Surgical Risk: Results From the CoreValve US Pivotal Trial.

D. Adams, J. Popma, S. Arnold, 2015, JACC. Cardiovascular interventions.

Predictors of Poor Outcomes After Transcatheter Aortic Valve Replacement: Results From the PARTNER (Placement of Aortic Transcatheter Valve) Trial

M. Mack, A. Kirtane, M. Leon, 2014, Circulation.

How to Define a Poor Outcome After Transcatheter Aortic Valve Replacement: Conceptual Framework and Empirical Observations From the Placement of Aortic Transcatheter Valve (PARTNER) Trial

M. Mack, J. Spertus, A. Kirtane, 2013, Circulation. Cardiovascular quality and outcomes.

Use of the Kansas City Cardiomyopathy Questionnaire for Monitoring Health Status in Patients With Aortic Stenosis

J. Spertus, L. Svensson, M. Leon, 2013, Circulation. Heart failure.

Martin B Leon, David J Cohen, M. Leon, 2012, Journal of the American College of Cardiology.

Bivalirudin and Provisional Glycoprotein IIb/IIIa Blockade Compared With Heparin and Planned Glycoprotein IIb/IIIa Blockade During Percutaneous Coronary Intervention

E. Topol, W. Desmet, A. Lincoff, 2003 .

Prognostic implications of procedural vs spontaneous myocardial infarction: results from the Evaluation of Drug Eluting Stents and Ischemic Events (EVENT) registry.

M. Pencina, S. Bangalore, N. Kleiman, 2013, American heart journal.

Myocardial Infarction After Carotid Stenting and Endarterectomy: Results From the Carotid Revascularization Endarterectomy Versus Stenting Trial

J. Eidt, T. Brott, R. Prineas, 2011, Circulation.

Outcome of multivessel coronary intervention in the contemporary percutaneous revascularization era.

E. Topol, G. Stone, M. Shishehbor, 2006, The American journal of cardiology.

Correlates and outcomes of late and very late drug-eluting stent thrombosis: results from DESERT (International Drug-Eluting Stent Event Registry of Thrombosis).

T. Ryan, L. Räber, A. Kirtane, 2014, JACC. Cardiovascular interventions.

STS-ACC TVT Registry of Transcatheter Aortic Valve Replacement.

J. Carroll, M. Mack, J. Bavaria, 2020, Journal of the American College of Cardiology.

Variation in post‐TAVR antiplatelet therapy utilization and associated outcomes: Insights from the STS/ACC TVT Registry

M. Mack, J. Rumsfeld, A. Kirtane, 2018, American heart journal.

Incidence, predictors, and prognostic impact of late bleeding complications after transcatheter aortic valve replacement.

M. Mack, M. Leon, J. Webb, 2014, Journal of the American College of Cardiology.

Impact of Smoking on Clinical and Angiographic Restenosis After Percutaneous Coronary Intervention: Another Smoker’s Paradox?

J. Popma, D. Cohen, D. Cutlip, 2001, Circulation.

Cost-effectiveness of edoxaban vs warfarin in patients with atrial fibrillation based on results of the ENGAGE AF-TIMI 48 trial.

E. Antman, R. Giugliano, D. Cohen, 2015, American heart journal.

on a National Heart, Lung and Blood Institute Working Group Guided Antithrombotic Therapy: Current Status and Future Research Direction: Report

Deepak L. Bhatt, V. Fuster, R. Califf, 2014 .

Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2).

M. Mack, P. Serruys, A. Kirtane, 2012, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Safety and Efficacy of Ticagrelor Monotherapy According to Drug-Eluting Stent Type: The TWILIGHT-STENT Study.

Samin K. Sharma, S. Pocock, M. Krucoff, 2021, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Outcomes of optimal or "stent-like"balloon angioplasty in acutemyocardial infarction: the CADILLAC trial.

J. J. Griffin, G. Stone, C. Grines, 2003, Journal of the American College of Cardiology.

Impact of Ejection Fraction and Aortic Valve Gradient on Outcomes of Transcatheter Aortic Valve Replacement.

Sean M. O'Brien, D. Holmes, H. Herrmann, 2016, Journal of the American College of Cardiology.

Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting Stents: Risk Scores From PARIS.

S. Pocock, G. Stone, T. Henry, 2016, Journal of the American College of Cardiology.

Age and Outcomes After Carotid Stenting and Endarterectomy: The Carotid Revascularization Endarterectomy Versus Stenting Trial

T. Brott, G. Howard, B. Lal, 2011, Stroke.

Clinical trials in coronary angiogenesis: issues, problems, consensus: An expert panel summary.

R O Bonow, Atlanta, R. Bonow, 2000, Circulation.

Drug‐eluting stent task force: Final report and recommendations of the working committees on cost‐effectiveness/economics, access to care, and medicolegal issues

G. Stone, L. Klein, D. Cohen, 2004, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Are drug-eluting stents cost-effective? It depends on whom you ask.

David J Cohen, D. Cohen, Jason Ryan, 2006, Circulation.

Will drug-eluting stents bankrupt the healthcare system?

D. Cohen, J. Ryan, D. Cohen, 2006 .

Appropriate patient selection or health care rationing? Lessons from surgical aortic valve replacement in the Placement of Aortic Transcatheter Valves I trial.

M. Mack, J. Bavaria, L. Cohn, 2015, The Journal of thoracic and cardiovascular surgery.

A randomized trial to evaluate the relative protection against post-percutaneous coronary intervention microvascular dysfunction, ischemia, and inflammation among antiplatelet and antithrombotic agents: the PROTECT-TIMI-30 trial.

E. Braunwald, P. Stone, D. Morrow, 2006, Journal of the American College of Cardiology.

Ischemic and bleeding outcomes in women treated with bivalirudin during percutaneous coronary intervention: a subgroup analysis of the Randomized Evaluation in PCI Linking Angiomax to Reduced Clinical Events (REPLACE)-2 trial.

E. Topol, A. Lincoff, A. Lansky, 2006, American heart journal.

Clinical Tria Randomized Trial to Evaluate the elative Protection Against Post-Percutaneous oronary Intervention Microvascular ysfunction , Ischemia , and Inflammation mong Antiplatelet and Antithrombotic Agents he PROTECT – TIMI-30 Trial

E. Braunwald, P. Stone, D. Morrow, 2006 .

Measuring and improving quality of care : A report from the american heart Association/American college of cardiology first scientific forum on assessment of healthcare quality in cardiovascular disease and stroke

B. McNeil, P. Wolf, E. DeLong, 2000, Stroke.

Imaging features and safety and efficacy of endovascular stroke treatment: a meta-analysis of individual patient-level data.

Renan Sales Barros, Hester F. Lingsma, Ivo G. H. Jansen, 2018, The Lancet. Neurology.

Severity of and Recovery From Anemia After Transcatheter Aortic Valve Replacement: An Analysis of the Placement of Aortic Transcatheter Valves Trial and Registries

I. Palacios, D. Kolte, M. Leon, 2022, Journal of the Society for Cardiovascular Angiography & Interventions.

Cost-Effectiveness of Sirolimus-Eluting Stents for Treatment of Complex Coronary Stenoses: Results From the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SIRIUS) Trial

Ameet Bakhai, Chunxue Shi, Tara Lavelle, 2004, Circulation.

1-Year Outcomes following Bioprosthetic Valve Fracture to Facilitate Valve-in-Valve Transcatheter Aortic Valve Replacement

E. Tseng, J. Webb, B. Whisenant, 2021 .

Bioprosthetic Valve Remodeling of Trifecta Surgical Valves to Facilitate Valve-in-Valve TAVR

D. Dvir, D. Cohen, K. Allen, 2020 .

Complications of Bioprosthetic Valve Fracture as an Adjunct to Valve-in-Valve TAVR

D. Dvir, B. Whisenant, D. Cohen, 2019, Structural Heart.

Is Bioprosthetic Valve Fracture Beneficial for Patients with Larger Surgical Valves Undergoing Valve in Valve TAVR?

D. Cohen, K. Allen, A. Chhatriwalla, 2018, Current Cardiology Reports.

Bioprosthetic Valve Fracture During Valve-in-valve TAVR: Bench to Bedside.

D. Cohen, K. Allen, A. Chhatriwalla, 2017, Interventional cardiology.

Economic evaluation of bivalirudin with provisional glycoprotein IIB/IIIA inhibition versus heparin with routine glycoprotein IIB/IIIA inhibition for percutaneous coronary intervention: results from the REPLACE-2 trial.

E. Topol, A. Lincoff, T. Lavelle, 2004, Journal of the American College of Cardiology.

Red cell distribution width is a predictor of mortality in patients undergoing percutaneous coronary intervention

M. Pencina, N. Kleiman, D. Cohen, 2012, Journal of Thrombosis and Thrombolysis.

Rationale and design of the Affordability and Real-world Antiplatelet Treatment Effectiveness after Myocardial Infarction Study (ARTEMIS): A multicenter, cluster-randomized trial of P2Y12 receptor inhibitor copayment reduction after myocardial infarction.

K. Anstrom, C. Cannon, T. Henry, 2016, American heart journal.

Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents.

Braunwald, S. Normand, E. Braunwald, 2014, The New England journal of medicine.

Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study

Antonio Colombo, Mitchell W Krucoff, George Dangas, 2013, The Lancet.

Association between use of bleeding avoidance strategies and risk of periprocedural bleeding among patients undergoing percutaneous coronary intervention.

John A Spertus, David J Cohen, John S Rumsfeld, 2010, JAMA.

Characteristics, management, and outcomes of 5,557 patients age > or =90 years with acute coronary syndromes: results from the CRUSADE Initiative.

K. Alexander, W. Gibler, E. Ohman, 2007, Journal of the American College of Cardiology.

Quality-of-Life Outcomes After Transcatheter Aortic Valve Replacement in an Unselected Population: A Report From the STS/ACC Transcatheter Valve Therapy Registry

M. Mack, J. Spertus, J. Rumsfeld, 2017, JAMA cardiology.

Clinical and economic outcomes after surgical aortic valve replacement in Medicare patients

Mary Ann Clark, David J Cohen, R. Bonow, 2012, Risk management and healthcare policy.

Five-year Clinical and Economic Outcomes Among Patients With Medically Managed Severe Aortic Stenosis: Results From a Medicare Claims Analysis

R. Bonow, L. Svensson, S. Arnold, 2012 .

Five-year clinical and economic outcomes among patients with medically managed severe aortic stenosis: results from a Medicare claims analysis.

R. Bonow, L. Svensson, S. Arnold, 2011, Circulation. Cardiovascular quality and outcomes.

Quality of life among patients with severe aortic stenosis

A. Bogers, D. Cohen, A. Kappetein, 2012, Netherlands Heart Journal.

In‐Hospital and 1‐year outcomes with drug‐eluting versus bare metal stents in saphenous vein graft intervention: A report from the EVENT registry

J. Massaro, E. Brilakis, N. Kleiman, 2012, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Design of a registry to characterize "real-world" outcomes of percutaneous coronary revascularization in the drug-eluting stent era.

David J Cohen, J. Massaro, N. Kleiman, 2005, American heart journal.

Stratification of outcomes after transcatheter aortic valve replacement according to surgical inoperability for technical versus clinical reasons.

P. Teirstein, M. Mack, J. Bavaria, 2014, Journal of the American College of Cardiology.

Rethinking Composite End Points in Clinical Trials: Insights From Patients and Trialists

J. Spertus, P. Chan, D. Cohen, 2014, Circulation.

Can we afford to eliminate restenosis? Can we afford not to?

D. Cohen, A. Bakhai, D. Greenberg, 2004, Journal of the American College of Cardiology.

Why Is Intravascular Ultrasound Guidance Underutilized in Percutaneous Coronary Intervention?: It Is Not "All About the Benjamins".

D. Cohen, Khanjan B Shah, Khanjan B. Shah, 2021, Circulation. Cardiovascular quality and outcomes.

Transcarotid Versus Transapical and Transaortic Access for Transcatheter Aortic Valve Replacement.

D. Cohen, K. Allen, A. Chhatriwalla, 2019, The Annals of thoracic surgery.

Incidence and treatment of 'no-reflow' after percutaneous coronary intervention.

D. Baim, D. Cohen, C. Gibson, 1994, Circulation.

Optimal Timing of Intervention in Non–ST-Segment Elevation Acute Coronary Syndromes: Insights From the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) Registry

E. DeLong, S. Normand, C. Cannon, 2005, Circulation.

Clinical and economic outcomes of multivessel coronary stenting compared with bypass surgery: a single-center US experience.

D. Cohen, M. Reynolds, K. Ho, 2003, American heart journal.

In-hospital and 1-year outcomes among unselected percutaneous coronary intervention patients treated with either sirolimus- or paclitaxel-eluting stents: results from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registry.

M. Pencina, S. Goldberg, V. Novack, 2009, JACC. Cardiovascular interventions.

Durability of quality of life benefits of transcatheter aortic valve replacement: Long‐term results from the CoreValve US extreme risk trial

D. Adams, J. Popma, S. Arnold, 2017, American heart journal.

Prediction of Poor Outcome After Transcatheter Aortic Valve Replacement.

D. Adams, J. Spertus, J. Afilalo, 2016, Journal of the American College of Cardiology.

D. Cohen, E. Armstrong, E. Magnuson, 2021, Journal of medical economics.

Do the benefits of new technology outweigh the costs?

D. Cohen, A. Bakhai, Dan Gremberg, 2003 .

Cost-Effectiveness of Gamma Radiation for Treatment of In-Stent Restenosis: Results From the Gamma-1 Trial

P. Teirstein, M. Leon, D. Cohen, 2002, Circulation.

Cost-Effectiveness of Percutaneous Coronary Interventions

D. Cohen, A. Bakhai, D. Cohen, 2003 .

Examining the economic impact of restenosis: implications for the cost-effectiveness of an antiproliferative stent

D. Cohen, D. Greenberg, D. Cohen, 2002, Zeitschrift für Kardiologie.

Predicting In-Hospital Mortality in Patients With Acute Myocardial Infarction.

J. Spertus, R. McNamara, D. Cohen, 2016, Journal of the American College of Cardiology.

Health status after transcatheter aortic valve replacement in patients at extreme surgical risk: results from the CoreValve U.S. trial.

D. Adams, J. Popma, T. Burdon, 2015, JACC. Cardiovascular interventions.

TAVI or No TAVI: identifying patients unlikely to benefit from transcatheter aortic valve implantation.

B. Iung, D. Cohen, R. Puri, 2016, European heart journal.

Cost-effectiveness of transcatheter aortic valve replacement compared with surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results of the PARTNER (Placement of Aortic Transcatheter Valves) trial (Cohort A).

M. Mack, J. Bavaria, L. Svensson, 2012, Journal of the American College of Cardiology.

TCT-892 Predictors of “futility” with transcutaneous aortic valve replacement therapy (TAVR): An analysis from the PARTNER randomized trial

M. Mack, A. Kirtane, M. Leon, 2012 .

Rheolytic thrombectomy and platelet glycoprotein IIb/IIIa blockade for stent thrombosis

D. Cohen, D. Cutlip, S. Rinfret, 2002, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Effectiveness of rheolytic coronary thrombectomy with the AngioJet catheter.

D. Baim, D. Cohen, S. Rinfret, 2002, The American journal of cardiology.

Evaluating the potential cost-effectiveness of stenting as a treatment for symptomatic single-vessel coronary disease. Use of a decision-analytic model.

L. Goldman, M. Weinstein, D. Baim, 1994, Circulation.

Drug-eluting stents for ST[corrected]-elevation acute myocardial infarction: do we need randomized trials?

Duane S Pinto, J. Ryan, D. Cohen, 2006, Coronary artery disease.

Drug-eluting stents for stent thrombosis elevation acute myocardial infarction: do we need randomized trials?

Duane S Pinto, J. Ryan, D. Cohen, 2006 .

Outcomes of Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention Receiving an Oral Anticoagulant and Dual Antiplatelet Therapy: A Comparison of Clopidogrel Versus Prasugrel From the TRANSLATE-ACS Study.

J. Messenger, G. Stone, E. Peterson, 2015, JACC. Cardiovascular interventions.

Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either drug-eluting stent

M. Pencina, S. Normand, J. Massaro, 2010, American heart journal.

Predicting Restenosis of Drug-Eluting Stents Placed in Real-World Clinical Practice: Derivation and Validation of a Risk Model From the EVENT Registry

M. Pencina, L. Mauri, N. Kleiman, 2010, Circulation. Cardiovascular interventions.

In-hospital and 1-year outcomes among percutaneous coronary intervention patients with chronic kidney disease in the era of drug-eluting stents: a report from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registry.

M. Pencina, N. Kleiman, D. Cohen, 2009, JACC. Cardiovascular interventions.

Association of Smoking Status With Long‐Term Mortality and Health Status After Transcatheter Aortic Valve Replacement: Insights From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry

J. Spertus, A. Kosinski, S. Arnold, 2019, Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease.

Variation in Hospital Risk–Adjusted Mortality Rates Following Transcatheter Aortic Valve Replacement in the United States: A Report From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry

Sean M. O'Brien, J. Rumsfeld, E. Peterson, 2016, Circulation. Cardiovascular quality and outcomes.

Relation of patient age and mortality to reported contraindications to early beta-blocker use for non-ST-elevation acute coronary syndrome.

W. Gibler, E. Ohman, E. Peterson, 2009, American Journal of Cardiology.

Analysis of early out-of hospital mortality after transcatheter aortic valve implantation among patients with aortic stenosis successfully discharged from the hospital and alive at 30 days (from the placement of aortic transcatheter valves trial).

M. Mack, A. Kirtane, M. Leon, 2014, The American journal of cardiology.

Measuring and improving quality of care: a report from the American Heart Association/American College of Cardiology First Scientific Forum on Assessment of Healthcare Quality in Cardiovascular Disease and Stroke.

B. McNeil, P. Wolf, E. DeLong, 2000, Circulation.

Cost-effectiveness of distal embolic protection for patients undergoing percutaneous intervention of saphenous vein bypass grafts: results from the SAFER trial.

S. Murphy, D. Baim, T. Lavelle, 2004, Journal of the American College of Cardiology.

The Vancouver 3M (Multidisciplinary, Multimodality, But Minimalist) Clinical Pathway Facilitates Safe Next-Day Discharge Home at Low-, Medium-, and High-Volume Transfemoral Transcatheter Aortic Valve Replacement Centers: The 3M TAVR Study.

J. Leipsic, D. Wood, T. Nazif, 2019, JACC. Cardiovascular interventions.

In-hospital and one-year economic outcomes after coronary stenting or balloon angioplasty. Results from a randomized clinical trial. Stent Restenosis Study Investigators.

H. Krumholz, J. Moses, M. Savage, 1995, Circulation.

Relation of frailty to outcomes after transcatheter aortic valve replacement (from the PARTNER trial).

M. Mack, A. Kirtane, M. Leon, 2015, The American journal of cardiology.

Stenting and medical therapy for atherosclerotic renal-artery stenosis.

Ralph B D'Agostino, Martin R Prince, David J Cohen, 2014, The New England journal of medicine.

Nuisance bleeding with prolonged dual antiplatelet therapy after acute myocardial infarction and its impact on health status.

K. Alexander, J. Spertus, R. Bach, 2013, Journal of the American College of Cardiology.

Combining clinical and angiographic variables for estimating risk of target lesion revascularization after drug eluting stent placement.

M. Pencina, J. Spertus, N. Kleiman, 2017, Cardiovascular revascularization medicine : including molecular interventions.

Transcatheter Versus Surgical Aortic Valve Replacement: Propensity-Matched Comparison.

Sean M. O'Brien, M. Pencina, M. Mack, 2017, Journal of the American College of Cardiology.

Cost-Effectiveness of Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Intermediate Risk: Results From the PARTNER 2 Trial

M. Mack, L. Svensson, M. Leon, 2019, Circulation.

Ultra-low-contrast angiography in patients with advanced chronic kidney disease and previous coronary artery bypass surgery

G. Stone, A. Kirtane, Z. Ali, 2019, Coronary artery disease.

Long-Term Survival Following Multivessel Revascularization in Patients With Diabetes The

Samin K. Sharma, V. Fuster, M. Domanski, 2019 .

ACCF/AHA Methodology for the Development of Quality Measures for Cardiovascular Technology: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures

E. DeLong, R. Hendel, D. Goff, 2011, Circulation.

Economic impact of GPIIB/IIIA blockade after high-risk angioplasty: results from the RESTORE trial. Randomized Efficacy Study of Tirofiban for Outcomes and Restenosis.

W. Weintraub, A. Kosinski, D. Cohen, 1999, Journal of the American College of Cardiology.

Statin therapy in patients with chronic kidney disease undergoing percutaneous coronary intervention (from the Evaluation of Drug Eluting Stents and Ischemic Events Registry).

N. Kleiman, D. Cohen, M. Keyes, 2014, The American journal of cardiology.

Prognostic impact of periprocedural bleeding and myocardial infarction after percutaneous coronary intervention in unselected patients: results from the EVENT (evaluation of drug-eluting stents and ischemic events) registry.

M. Pencina, S. Goldberg, N. Kleiman, 2009, JACC. Cardiovascular interventions.

Impact of Pacemaker Implantation on 12-Month Resource Utilization Following TAVR Hospitalization

D. Cohen, M. Reynolds, S. Culler, 2019, Journal of Cardiology and Cardiovascular Medicine.

Trends in isolated aortic valve replacement in the United States in the early phase of expansion of TAVR.

R. Yeh, J. Popma, D. Cohen, 2019, International journal of cardiology.

Exploring the Reduction in Hospitalization Costs Associated with Next-Day Discharge following Transfemoral Transcatheter Aortic Valve Replacement in the United States

D. Wood, S. Lauck, J. Webb, 2019, Structural Heart.

Trends in Aortic Valve Replacement Procedures Between 2009 and 2015: Has Transcatheter Aortic Valve Replacement Made a Difference?

D. Cohen, M. Reynolds, S. Culler, 2018, The Annals of thoracic surgery.

Inclusion of Functional Status Measures in the Risk Adjustment of 30-Day Mortality After Transcatheter Aortic Valve Replacement: A Report From the Society of Thoracic Surgeons/American College of Cardiology TVT Registry.

Sean M. O'Brien, F. Grover, E. Peterson, 2018, JACC. Cardiovascular interventions.

Effects of N-acetylcysteine on endothelial function and inflammation in patients with type 2 diabetes mellitus

A. Jeremias, E. Horton, D. Cohen, 2009 .

Improvements in Symptoms and Quality of Life in Patients With Paroxysmal Atrial Fibrillation Treated With Radiofrequency Catheter Ablation Versus Antiarrhythmic Drugs

D. Cohen, M. Reynolds, D. Wilber, 2010, Circulation. Cardiovascular quality and outcomes.

Cost-Effectiveness of Radiofrequency Catheter Ablation Compared With Antiarrhythmic Drug Therapy for Paroxysmal Atrial Fibrillation

David J Cohen, Mark E Josephson, M. Josephson, 2009, Circulation. Arrhythmia and electrophysiology.

Transcatheter Mitral‐Valve Repair in Patients with Heart Failure

M. Mack, G. Stone, N. Weissman, 2018, The New England journal of medicine.

Economic Impact of Angina After an Acute Coronary Syndrome: Insights From the MERLIN-TIMI 36 Trial

E. Braunwald, D. Morrow, P. Chan, 2009, Circulation. Cardiovascular quality and outcomes.

The impact of dyspnea on health-related quality of life in patients with coronary artery disease: results from the PREMIER registry.

J. Spertus, S. Arnold, D. Cohen, 2009, American heart journal.

Effects of Ranolazine on Disease-Specific Health Status and Quality of Life Among Patients With Acute Coronary Syndromes: Results from the MERLIN-TIMI 36 Randomized Trial

E. Braunwald, D. Morrow, B. Scirica, 2008, Circulation. Cardiovascular quality and outcomes.

Trial Economic Impact of Angina After an Acute Coronary Syndrome : Insights

E. Braunwald, D. Morrow, P. Chan, 2009 .

Bleeding Risk Comparing Targeted Low-Dose Heparin With Bivalirudin in Patients Undergoing Percutaneous Coronary Intervention: Results From a Propensity Score–Matched Analysis of the Evaluation of Drug-Eluting Stents and Ischemic Events (EVENT) Registry

M. Pencina, L. Mauri, S. Bangalore, 2011, Circulation. Cardiovascular interventions.

Early Cessation of Adenosine Diphosphate Receptor Inhibitors Among Acute Myocardial Infarction Patients Treated With Percutaneous Coronary Intervention: Insights From the TRANSLATE-ACS Study (Treatment With Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and

K. Anstrom, J. Messenger, E. Peterson, 2016, Circulation. Cardiovascular interventions.

Predictors of Clinical Response to Transcatheter Reduction of Secondary Mitral Regurgitation: The COAPT Trial.

M. Mack, G. Stone, V. Rajagopal, 2020, Journal of the American College of Cardiology.

Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization.

E. Topol, G. Stone, C. Grines, 2001, The New England journal of medicine.

SEX–SPECIFIC DIFFERENCES IN LATE MORTALITY AFTER TRANSCATHETER AVR IN THE PARTNER TRIAL

N. Weissman, E. Tuzcu, A. Kirtane, 2013 .

M. Mack, N. Weissman, E. Tuzcu, 2022 .

Percutaneous Coronary Revascularization in Elderly Patients: Impact on Functional Status and Quality of Life

T. Seto, D. Cohen, K. Ho, 2000, Annals of Internal Medicine.

Heparin Monotherapy or Bivalirudin During Percutaneous Coronary Intervention in Patients With Non–ST-Segment–Elevation Acute Coronary Syndromes or Stable Ischemic Heart Disease: Results From the Evaluation of Drug-Eluting Stents and Ischemic Events Registry

M. Pencina, S. Bangalore, N. Kleiman, 2014, Circulation. Cardiovascular Interventions.

TCT-36 Frailty in Intermediate Risk Patients Undergoing Transcatheter or Surgical Aortic Valve Replacement, Cut Points and Relationship With Outcomes: An Analysis of the Placement of Aortic Transcatheter Valves (PARTNER) 2 Cohort A Randomized Trial.

M. Mack, A. Kirtane, T. Nazif, 2016, Journal of the American College of Cardiology.

Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative.

Deepak L. Bhatt, C. Cannon, W. Gibler, 2005, JAMA.

Health-Status Outcomes with Invasive or Conservative Care in Coronary Disease.

Sean M. O'Brien, F. Harrell, D. Mark, 2020, The New England journal of medicine.

Ticagrelor monotherapy in patients with chronic kidney disease undergoing percutaneous coronary intervention: TWILIGHT-CKD.

Samin K. Sharma, M. Krucoff, G. Dangas, 2021, European heart journal.

Sex Differences Among Patients With High Risk Receiving Ticagrelor With or Without Aspirin After Percutaneous Coronary Intervention: A Subgroup Analysis of the TWILIGHT Randomized Clinical Trial.

Samin K. Sharma, S. Pocock, E. Ohman, 2021, JAMA cardiology.

Ticagrelor alone vs. ticagrelor plus aspirin following percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: TWILIGHT-ACS.

Samin K. Sharma, S. Pocock, E. Ohman, 2020, European heart journal.

Ticagrelor With or Without Aspirin After Complex PCI

Samin K. Sharma, S. Pocock, G. Dangas, 2020 .

Ticagrelor with or without Aspirin in High-Risk Patients with Diabetes Mellitus undergoing Percutaneous Coronary Intervention.

Samin K. Sharma, S. Pocock, G. Dangas, 2020, Journal of the American College of Cardiology.

Patterns and Impact of Dual Antiplatelet Cessation on Cardiovascular Risk After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndromes.

S. Pocock, T. Henry, M. Krucoff, 2019, American Journal of Cardiology.

Tailoring Antiplatelet Therapy Intensity to Ischemic and Bleeding Risk: A Cost Consequence Simulation From PARIS

S. Pocock, T. Henry, M. Krucoff, 2019, Circulation. Cardiovascular quality and outcomes.

Diagnosis and Management of Cardiovascular Disease in Advanced and End‐Stage Renal Disease

Navdeep K. Bhatti, G. Stone, A. Kirtane, 2016, Journal of the American Heart Association.

Bleeding complications after surgical aortic valve replacement compared with transcatheter aortic valve replacement: insights from the PARTNER I Trial (Placement of Aortic Transcatheter Valve).

M. Mack, A. Kirtane, L. Svensson, 2014, Journal of the American College of Cardiology.

Short- and Intermediate-Term Clinical Outcomes From Direct Myocardial Laser Revascularization Guided by Biosense Left Ventricular Electromechanical Mapping

R. Hendel, R. Bonow, J. Moses, 2000, Circulation.

Impact of patient characteristics, complications, and facility volume on the costs and time of cardiac catheterization and coronary angioplasty in 70 catheterization laboratories.

E R Becker, S D Culler, W. Weintraub, 2000, The American journal of cardiology.

Cost-Effectiveness of Dual-Chamber Pacing Compared With Ventricular Pacing for Sinus Node Dysfunction

L. Goldman, G. Lamas, M. Weinstein, 2005, Circulation.

Association between bleeding events and in-hospital mortality after percutaneous coronary intervention.

David J Cohen, J. Messenger, D. Cohen, 2013, JAMA.

Impact of Glycoprotein IIb/IIIa Inhibition in Contemporary Percutaneous Coronary Intervention for Acute Coronary Syndromes: Insights From the National Cardiovascular Data Registry.

David J Cohen, D. Cohen, K. Kennedy, 2015, JACC. Cardiovascular interventions.

Interpreting the results of cost-effectiveness studies.

D. Cohen, M. Reynolds, D. Cohen, 2008, Journal of the American College of Cardiology.

Willingness to pay for avoiding coronary restenosis and repeat revascularization: results from a contingent valuation study.

D. Cohen, P. Neumann, A. Bakhai, 2004, Health policy.

In-hospital costs of self-expanding nitinol stent implantation versus balloon angioplasty in the femoropopliteal artery (the VascuCoil Trial).

T. Lavelle, D. Cohen, K. Rosenfield, 2004, Journal of vascular and interventional radiology : JVIR.

Cost-Effectiveness of Coronary Stenting in Acute Myocardial Infarction: Results From the Stent Primary Angioplasty in Myocardial Infarction (Stent-PAMI) Trial

G. Stone, C. Grines, M. Morice, 2001, Circulation.

Ticagrelor with or without Aspirin in High-Risk Patients after PCI.

Samin K. Sharma, S. Pocock, E. Ohman, 2019, The New England journal of medicine.

Biodegradable-polymer drug-eluting stents vs. bare metal stents vs. durable-polymer drug-eluting stents: a systematic review and Bayesian approach network meta-analysis.

Hyun-Jae Kang, Young-Bae Park, Si-Hyuck Kang, 2014, European heart journal.

Hospital Delays in Reperfusion for ST-Elevation Myocardial Infarction: Implications When Selecting a Reperfusion Strategy

David P Miller, E. Antman, C. Cannon, 2006, Circulation.

Penumbral imaging and functional outcome in patients with anterior circulation ischaemic stroke treated with endovascular thrombectomy versus medical therapy: a meta-analysis of individual patient-level data

Michael T. McManus, Renan Sales Barros, Hester F. Lingsma, 2019, The Lancet Neurology.

Bleeding Risk, Dual Antiplatelet Therapy Cessation, and Adverse Events After Percutaneous Coronary Intervention

S. Pocock, T. Henry, M. Krucoff, 2020, Circulation. Cardiovascular interventions.

L. Goldstein, T. Brott, G. Howard, 2011, Journal of the American College of Cardiology.

Stenting versus endarterectomy for treatment of carotid-artery stenosis.

Michael D Hill, George Howard, Stanley N Cohen, 2010, The New England journal of medicine.

Outcomes in Nonagenarians Undergoing Transcatheter Aortic Valve Replacement in the PARTNER-I Trial.

C. Don, M. Mack, L. Svensson, 2015, The Annals of thoracic surgery.

Bioprosthetic Valve Fracture Improves the Hemodynamic Results of Valve-in-Valve Transcatheter Aortic Valve Replacement

D. Dvir, D. Cohen, K. Allen, 2017, Circulation. Cardiovascular interventions.

Incidence ,

S. Pocock, T. Henry, M. Krucoff, 2018 .

Ticagrelor monotherapy in patients at high bleeding risk undergoing percutaneous coronary intervention: TWILIGHT-HBR.

Samin K. Sharma, M. Krucoff, G. Dangas, 2021, European heart journal.

Comparison of Effects of Abciximab Versus Eptifibatide on C-Reactive Protein, Interleukin-6, and Interleukin- 1 Receptor Antagonist After Coronary Arterial Stenting

R. Bonow, S. Fuchs, D. Cohen, 2003 .

Frequency of Poor Outcome (Death or Poor Quality of Life) After Left Ventricular Assist Device for Destination Therapy: Results From the INTERMACS Registry

L. Allen, J. Spertus, S. Arnold, 2016, Circulation. Heart failure.

Trial of everolimus-eluting stents or bypass surgery for coronary disease.

A. Yeung, M. Jeong, K. Seung, 2015, The New England journal of medicine.

Frequency of major noncardiac surgery and subsequent adverse events in the year after drug-eluting stent placement results from the EVENT (Evaluation of Drug-Eluting Stents and Ischemic Events) Registry.

M. Pencina, S. Steinhubl, A. Jeremias, 2010, JACC. Cardiovascular interventions.

Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention in Patients With Diabetes: Insights From the OPEN CTO Registry.

J. Spertus, J. Moses, D. Cohen, 2017, JACC. Cardiovascular interventions.

Long-Term Survival Following Multivessel Revascularization in Patients With Diabetes: The FREEDOM Follow-On Study.

Samin K. Sharma, V. Fuster, M. Domanski, 2019, Journal of the American College of Cardiology.

Depression and Angina Among Patients Undergoing Chronic Total Occlusion Percutaneous Coronary Intervention: The OPEN-CTO Registry.

J. Spertus, F. Jaffer, R. Yeh, 2019, JACC. Cardiovascular interventions.

Patterns and associations between DAPT cessation and 2-year clinical outcomes in left main/proximal LAD versus other PCI: Results from the Patterns of Non-Adherence to Dual Antiplatelet Therapy in Stented Patients (PARIS) registry.

S. Pocock, T. Henry, G. Dangas, 2017, International journal of cardiology.

Design and rationale for a randomised comparison of everolimus-eluting stents and coronary artery bypass graft surgery in selected patients with left main coronary artery disease: the EXCEL trial.

B. Gersh, S. Pocock, P. Serruys, 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Utilization of Early Invasive Management Strategies for High-Risk Patients With Non–ST-Segment Elevation Acute Coronary Syndromes: Results From the CRUSADE Quality Improvement Initiative

Deepak L. Bhatt, C. Cannon, E. Ohman, 2004 .

Management of Persistent Angina After Myocardial Infarction Treated With Percutaneous Coronary Intervention: Insights From the TRANSLATE‐ACS Study

E. Peterson, G. Fonarow, D. Cohen, 2017, Journal of the American Heart Association.

Cost-Effectiveness of Tafamidis Therapy for Transthyretin Amyloid Cardiomyopathy

Sanjiv J. Shah, J. Spertus, M. Maurer, 2020, Circulation.

NYHA Functional Classification and Outcomes After Transcatheter Mitral Valve Repair in Heart Failure: The COAPT Trial.

M. Mack, G. Stone, N. Weissman, 2020, JACC. Cardiovascular interventions.

Association of Renin-Angiotensin Inhibitor Treatment With Mortality and Heart Failure Readmission in Patients With Transcatheter Aortic Valve Replacement

J. Carroll, J. Bavaria, A. Kirtane, 2018, JAMA.

Incidence ,

S. Pocock, T. Henry, M. Krucoff, 2018 .

Development and Validation of an Ischemic and Bleeding Risk Evaluation Tool in East Asian Patients Receiving Percutaneous Coronary Intervention

D. Cohen, Hyo‐Soo Kim, Hyun-Jae Kang, 2019, Thrombosis and Haemostasis.

Long-Term Clinical Impact of Contrast-Associated Acute Kidney Injury Following PCI: An ADAPT-DES Substudy.

A. Jeremias, G. Stone, Z. Ali, 2022, JACC. Cardiovascular interventions.

Benefits and Risks of Extended Duration Dual Antiplatelet Therapy After PCI in Patients With and Without Acute Myocardial Infarction.

A. Jacobs, S. Windecker, J. Massaro, 2015, Journal of the American College of Cardiology.

Causes, Timing, and Impact of Dual Antiplatelet Therapy Interruption for Surgery (from the Patterns of Non-adherence to Anti-platelet Regimens In Stented Patients Registry).

S. Pocock, T. Henry, G. Dangas, 2017, The American journal of cardiology.

Balancing the risks of bleeding and stent thrombosis: a decision analytic model to compare durations of dual antiplatelet therapy after drug-eluting stents.

L. Mauri, R. Yeh, D. Cohen, 2015, American heart journal.

Impact of Smoking on Health-Related Quality of Life After Percutaneous Coronary Revascularization

H. Krumholz, T. Seto, D. Cohen, 2000, Circulation.

Performance and Validation of the U.S. NCDR Acute Kidney Injury Prediction Model in Japan.

H. Miyata, J. Spertus, J. Rumsfeld, 2016, Journal of the American College of Cardiology.

Ticagrelor With Aspirin or Alone After Complex PCI: The TWILIGHT-COMPLEX Analysis.

Samin K. Sharma, S. Pocock, G. Dangas, 2020, Journal of the American College of Cardiology.

Myocardial beta-adrenergic receptor function during the development of pacing-induced heart failure.

S. Vatner, D. Cohen, D. Vatner, 1993, The Journal of clinical investigation.

Dual-Antiplatelet Therapy Cessation and Cardiovascular Risk in Relation to Age: Analysis From the PARIS Registry.

S. Pocock, T. Henry, M. Krucoff, 2019, JACC. Cardiovascular interventions.

Effect of Medication Co-payment Vouchers on P2Y12 Inhibitor Use and Major Adverse Cardiovascular Events Among Patients With Myocardial Infarction: The ARTEMIS Randomized Clinical Trial

K. Anstrom, C. Cannon, T. Henry, 2019, JAMA.

Ticagrelor Monotherapy After PCI in High-Risk Patients With Prior MI: A Prespecified TWILIGHT Substudy.

Samin K. Sharma, T. Henry, M. Krucoff, 2022, JACC. Cardiovascular interventions.

Impact of Age on the Safety and Efficacy of Ticagrelor Monotherapy in Patients Undergoing PCI.

Samin K. Sharma, S. Pocock, M. Krucoff, 2021, JACC. Cardiovascular interventions.

Ticagrelor Monotherapy Versus Dual-Antiplatelet Therapy After PCI: An Individual Patient-Level Meta-Analysis.

Samin K. Sharma, S. Pocock, P. Serruys, 2021, JACC. Cardiovascular interventions.

Global Approach to High Bleeding Risk Patients With Polymer-Free Drug-Coated Coronary Stents

Sunil V. Rao, M. Price, S. Pocock, 2020, Circulation. Cardiovascular interventions.

Ticagrelor with aspirin or alone in high-risk patients after coronary intervention: Rationale and design of the TWILIGHT study.

S. Pocock, E. Ohman, M. Krucoff, 2016, American heart journal.

Time-Dependent Associations Between Actionable Bleeding, Coronary Thrombotic Events, and Mortality Following Percutaneous Coronary Intervention: Results From the PARIS Registry.

S. Pocock, T. Henry, M. Krucoff, 2016, JACC. Cardiovascular interventions.

Geographical Variations in Patterns of DAPT Cessation and Two-Year PCI Outcomes: Insights from the PARIS Registry

S. Pocock, T. Henry, M. Krucoff, 2019, Thrombosis and Haemostasis.

Incidence, Patterns, and Impact of Dual Antiplatelet Therapy Cessation Among Patients With and Without Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention: Results From the PARIS Registry (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients)

S. Pocock, T. Henry, M. Krucoff, 2018, Circulation. Cardiovascular interventions.

Incidence, Patterns, and Associations Between Dual-Antiplatelet Therapy Cessation and Risk for Adverse Events Among Patients With and Without Diabetes Mellitus Receiving Drug-Eluting Stents: Results From the PARIS Registry.

S. Pocock, T. Henry, M. Krucoff, 2017, JACC. Cardiovascular interventions.

White Blood Cell Count and Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention in the Contemporary Era: Insights From the PARIS Study (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients Registry)

S. Pocock, Binita Shah, T. Henry, 2017, Circulation. Cardiovascular interventions.

Vascular Hospitalization Rates and Costs in Patients With Peripheral Artery Disease in the United States

Deepak L. Bhatt, S. Duval, E. Mahoney, 2010, Circulation. Cardiovascular quality and outcomes.

Prediction of residual angina after percutaneous coronary intervention.

J. Spertus, S. Arnold, D. Cohen, 2015, European heart journal. Quality of care & clinical outcomes.

Intravenous Acetaminophen Improves Outcomes After Transapical Transcatheter Aortic Valve Replacement

D. Cohen, K. Allen, A. Michael Borkon, 2018, Innovations.

Cost-Effectiveness of Long-Term Ticagrelor in Patients With Prior Myocardial Infarction: Results From the PEGASUS-TIMI 54 Trial.

Marc P. Bonaca, Deepak L. Bhatt, M. Sabatine, 2017, Journal of the American College of Cardiology.

Association of measured platelet reactivity with changes in P2Y12 receptor inhibitor therapy and outcomes after myocardial infarction: Insights into routine clinical practice from the TReatment with ADP receptor iNhibitorS: Longitudinal Assessment of Treatment Patterns and Events after Acute Coronar

K. Anstrom, G. Stone, A. Bagai, 2017, American heart journal.

Bleeding risk following percutaneous coronary intervention in patients with diabetes prescribed dual anti-platelet therapy.

Deepak L. Bhatt, J. Spertus, Darren K Mcguire, 2016, American heart journal.

Contemporary use of platelet function and pharmacogenomic testing among patients with acute myocardial infarction undergoing percutaneous coronary intervention in the United States.

J. Messenger, T. Henry, E. Peterson, 2015, American heart journal.

Cluster-Randomized Clinical Trial Examining the Impact of Platelet Function Testing on Practice: The Treatment With Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome Prospective Open Label Antiplatelet Therapy Study

K. Anstrom, T. Henry, E. Peterson, 2015, Circulation. Cardiovascular interventions.

Guided antithrombotic therapy: current status and future research direction: report on a National Heart, Lung and Blood Institute working group.

Christopher J O'Donnell, Robert M Califf, Matthew J Price, 2012, Circulation.

Impact of multivessel revascularization on health status outcomes in patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease.

J. Spertus, S. Arnold, J. Grantham, 2015, Journal of the American College of Cardiology.

Transcatheter Mitral‐Valve Repair in Patients with Heart Failure

M. Mack, G. Stone, N. Weissman, 2018, The New England journal of medicine.

Predicting the EQ-5D from the Kansas City Cardiomyopathy Questionnaire (KCCQ) in Patients with Heart Failure.

G. Fonarow, J. Spertus, D. Cohen, 2021, European heart journal. Quality of care & clinical outcomes.

Randomized Trial Evaluating Percutaneous Coronary Intervention for the Treatment of Chronic Total Occlusion: The DECISION-CTO Trial

Seung‐Jung Park, S. Yun, Sang-Wook Lim, 2019, Circulation.

Impact of Bleeding on Quality of Life in Patients on DAPT: Insights From TRANSLATE-ACS.

E. Peterson, R. Bach, M. Effron, 2016, Journal of the American College of Cardiology.

ACCF/AHA methodology for the development of quality measures for cardiovascular technology: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures.

E. DeLong, R. Hendel, R. Bonow, 2011, Journal of the American College of Cardiology.

The challenges of success: maintaining access to high-quality percutaneous coronary intervention in the face of declining procedural volumes.

R. Yeh, D. Cohen, S. Baron, 2014, Circulation.

Use of drug-eluting stents as a function of predicted benefit: clinical and economic implications of current practice.

Sharon-Lise T Normand, Laura Mauri, John A Spertus, 2012, Archives of internal medicine.

Prevalence and Prognostic Significance of Preprocedural Cardiac Troponin Elevation Among Patients With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: Results From the Evaluation of Drug Eluting Stents and Ischemic Events Registry

M. Pencina, S. Goldberg, A. Jeremias, 2008, Circulation.

Relationship of Albuminuria and Renal Artery Stent OutcomesNovelty and Significance

R. D'Agostino, J. Massaro, S. Textor, 2016 .

Global Variation in the Prevalence of Elevated Cholesterol in Outpatients With Established Vascular Disease or 3 Cardiovascular Risk Factors According to National Indices of Economic Development and Health System Performance

Deepak L. Bhatt, E. Ohman, Sidney C. Smith, 2012, Circulation.

Influence of age, sex, and atrial fibrillation recurrence on quality of life outcomes in a population of patients with new-onset atrial fibrillation: the Fibrillation Registry Assessing Costs, Therapies, Adverse events and Lifestyle (FRACTAL) study.

P. Zimetbaum, T. Lavelle, D. Cohen, 2006, American heart journal.

Relation between six-minute walk test performance and outcomes after transcatheter aortic valve implantation (from the PARTNER trial).

M. Mack, A. Kirtane, M. Leon, 2013, The American journal of cardiology.

TAVI or No TAVI: identifying patients unlikely to benefit from transcatheter aortic valve implantation.

B. Iung, R. Puri, J. Rodés‐Cabau, 2016, European heart journal.

Definitions and Clinical Trial Design Principles for Coronary Artery Chronic Total Occlusion Therapies: CTO-ARC Consensus Recommendations.

R. Virmani, G. Stone, A. Finn, 2021, Circulation.

The frequency and incremental cost of major complications among medicare beneficiaries receiving implantable cardioverter-defibrillators.

D. Cohen, M. Reynolds, E. Becker, 2006, Journal of the American College of Cardiology.

Nephrogenic fibrosing dermopathy (scleromyxedema-like illness of renal disease).

D. Cohen, M. Hardy, J. Mackay-Wiggan, 2003, Journal of the American Academy of Dermatology.

Cost-Effectiveness of Solitaire Stent Retriever Thrombectomy for Acute Ischemic Stroke: Results From the SWIFT-PRIME Trial (Solitaire With the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke)

H. Diener, W. Hacke, R. Jahan, 2017, Stroke.

Michael T. McManus, Renan Sales Barros, Hester F. Lingsma, 2019, The Lancet. Neurology.

Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2).

M. Mack, P. Serruys, A. Kirtane, 2012, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Solitaire™ with the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke (SWIFT PRIME) trial: protocol for a randomized, controlled, multicenter study comparing the Solitaire revascularization device with IV tPA with IV tPA alone in acute ischemic stroke

H. Diener, W. Hacke, V. Reddy, 2015, International journal of stroke : official journal of the International Stroke Society.

Role of Frailty in Identifying Benefit From Transcatheter Versus Surgical Aortic Valve Replacement

J. Spertus, R. Gerszten, R. Yeh, 2021, Circulation. Cardiovascular quality and outcomes.

Identification of Frailty Using a Claims‐Based Frailty Index in the CoreValve Studies: Findings from the EXTEND‐FRAILTY Study

J. Spertus, R. Gerszten, R. Yeh, 2021, Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease.

Impact of a Claims-Based Frailty Indicator on the Prediction of Long-Term Mortality After Transcatheter Aortic Valve Replacement in Medicare Beneficiaries

R. Yeh, J. Popma, D. Cohen, 2018, Circulation. Cardiovascular quality and outcomes.

Cost Estimation of Cardiovascular Disease Events in the US

David Thompson, David J. Cohen, Amy K. O’Sullivan, 2011, PharmacoEconomics.

Prediction of Poor Outcome After Transcatheter Aortic Valve Replacement.

D. Adams, J. Spertus, J. Afilalo, 2016, Journal of the American College of Cardiology.

Balancing the risks of restenosis and stent thrombosis in bare-metal versus drug-eluting stents: results of a decision analytic model.

L. Mauri, T. Gaziano, Pallav Garg, 2008, Journal of the American College of Cardiology.

Switching of adenosine diphosphate receptor inhibitor after hospital discharge among myocardial infarction patients: Insights from the Treatment with Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome (TRANSLATE‐ACS) obse

K. Anstrom, J. Messenger, T. Henry, 2017, American heart journal.

M. Pencina, S. Goldberg, N. Kleiman, 2009, JACC. Cardiovascular interventions.

Mode of death after contemporary percutaneous coronary intervention: a report from the Evaluation of Drug Eluting Stents and Ischemic Events registry.

N. Kleiman, D. Cohen, K. Kennedy, 2011, American heart journal.

Prognostic Impact of Subsequent Acute Coronary Syndrome and Unplanned Revascularization on Long‐Term Mortality After an Index Percutaneous Coronary Intervention: A Report From a Japanese Multicenter Registry

H. Miyata, J. Spertus, Zhenxiang Zhao, 2017, Journal of the American Heart Association.

Cost-Effectiveness of Targeting Patients Undergoing Percutaneous Coronary Intervention for Therapy With Bivalirudin Versus Heparin Monotherapy According to Predicted Risk of Bleeding

J. Messenger, P. Chan, E. Mahoney, 2010, Circulation. Cardiovascular quality and outcomes.

Costs Associated With Access Site and Same-Day Discharge Among Medicare Beneficiaries Undergoing Percutaneous Coronary Intervention: An Evaluation of the Current Percutaneous Coronary Intervention Care Pathways in the United States.

J. Spertus, M. Patterson, D. Cohen, 2017, JACC. Cardiovascular interventions.

Heparin use for diagnostic cardiac catheterization with a radial artery approach: An international survey of practice patterns

Sunil V. Rao, S. Mehta, W. Cantor, 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Delay in reperfusion with transradial percutaneous coronary intervention for ST-elevation myocardial infarction: Might some delays be acceptable?

S. Rathore, L. Mauri, R. Yeh, 2014, American heart journal.

Drug-eluting stents and the use of percutaneous coronary intervention among patients with class I indications for coronary artery bypass surgery undergoing index revascularization: analysis from the NCDR (National Cardiovascular Data Registry).

J. Spertus, J. Rumsfeld, D. Cohen, 2009, JACC. Cardiovascular interventions.

Changes in patterns of coronary revascularization strategies for patients with acute coronary syndromes (from the CRUSADE Quality Improvement Initiative).

Manesh R. Patel, W. Gibler, E. Ohman, 2007, The American journal of cardiology.

Redevelopment and validation of the SYNTAX score II to individualise decision making between percutaneous and surgical revascularisation in patients with complex coronary artery disease: secondary analysis of the multicentre randomised controlled SYNTAXES trial with external cohort validation

V. Fuster, E. Steyerberg, D. Kent, 2020, The Lancet.

Quality of life after pharmacomechanical catheter-directed thrombolysis for proximal deep venous thrombosis.

J. Kaufman, S. Goldhaber, M. Jaff, 2020, Journal of vascular surgery. Venous and lymphatic disorders.

Cost-effectiveness analysis of short-duration dual antiplatelet therapy with newer drug-eluting stent platforms versus longer-duration dual antiplatelet therapy with a second-generation drug-eluting stent in elective percutaneous coronary intervention

R. Yeh, D. Cohen, E. Secemsky, 2019, Coronary artery disease.

Hospital resources consumed in treating complications associated with percutaneous coronary interventions.

D. Cohen, E. Becker, S. Culler, 2006, The American journal of cardiology.

Weighing the potential late benefits versus early hazard associated with bioresorbable vascular scaffolds in percutaneous coronary interventions: a Markov decision analytic model

R. Yeh, D. Cohen, R. Fazel, 2020, Coronary artery disease.

Multivessel Versus Culprit Vessel–Only Percutaneous Coronary Intervention Among Patients With Acute Myocardial Infarction: Insights From the TRANSLATE‐ACS Observational Study

E. Peterson, G. Fonarow, M. Effron, 2017, Journal of the American Heart Association.

Economic impact of same-day home discharge after uncomplicated transradial percutaneous coronary intervention and bolus-only abciximab regimen.

D. Cohen, S. Rinfret, J. Rodés‐Cabau, 2010, JACC. Cardiovascular interventions.

Benefits and Risks of Extended Duration Dual Antiplatelet Therapy After PCI in Patients With and Without Acute Myocardial Infarction.

S. Windecker, J. Massaro, L. Mauri, 2015, Journal of the American College of Cardiology.

Association of Physician Variation in Use of Manual Aspiration Thrombectomy With Outcomes Following Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction: The National Cardiovascular Data Registry CathPCI Registry

Sunil V. Rao, A. Kirtane, R. Yeh, 2019, JAMA cardiology.

Performance and Validation of the U.S. NCDR Acute Kidney Injury Prediction Model in Japan.

H. Miyata, J. Spertus, J. Rumsfeld, 2016, Journal of the American College of Cardiology.

Safety and Effectiveness of the SVELTE Fixed-Wire and Rapid Exchange Bioresorbable-Polymer Sirolimus-Eluting Coronary Stent Systems for the Treatment of Atherosclerotic Lesions

Sunil V. Rao, S. Saito, P. Stella, 2021, Circulation. Cardiovascular Interventions.

Impact of Periprocedural Myocardial Biomarker Elevation on Mortality Following Elective Percutaneous Coronary Intervention.

P. Serruys, S. Silber, S. Windecker, 2019, JACC. Cardiovascular interventions.

Rapid adoption of drug-eluting stents: clinical practices and outcomes from the early drug-eluting stent era.

M. Pencina, N. Kleiman, D. Cohen, 2010, American heart journal.

Importance of mitral regurgitation inpatients undergoing percutaneous coronary intervention for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial.

J. J. Griffin, G. Stone, W. O’Neill, 2004, Journal of the American College of Cardiology.

Cost-Effectiveness of Drug-Eluting Stents Versus Bare Metal Stents in Clinical Practice

D. Cohen, W. Little, R. Applegate, 2011, Circulation. Cardiovascular quality and outcomes.

Will drug-eluting stents bankrupt the healthcare system? Are Drug-Eluting Stents Cost-Effective? It Depends on Whom You Ask C ONTROVERSIES IN C ARDIOVASCULAR M EDICINE

D. Cohen, J. Ryan, D. Cohen, 2006 .

Impact of Ezetimibe on the Rate of Cardiovascular-Related Hospitalizations and Associated Costs Among Patients With a Recent Acute Coronary Syndrome: Results From the IMPROVE-IT Trial (Improved Reduction of Outcomes Vytorin Efficacy International Trial)

D. Mark, R. Giugliano, E. Braunwald, 2017, Circulation. Cardiovascular quality and outcomes.

The frequency and cost of complications associated with coronary artery bypass grafting surgery: results from the United States Medicare program.

D. Cohen, M. Reynolds, S. Culler, 2008, The Annals of thoracic surgery.

In-hospital costs of coronary stent implantation with and without eptifibatide (the ESPRIT Trial). Enhanced Suppression of the Platelet IIb/IIIa Receptor with Integrilin.

G. Levine, J. Tcheng, D. Cohen, 2002, The American journal of cardiology.

Predicting Likelihood for Coronary Artery Bypass Grafting After Non-ST-Elevation Myocardial Infarction: Finding the Best Prediction Model.

J. Spertus, D. Cohen, Jae-Sik Jang, 2016, The Annals of thoracic surgery.

Variation in Practice Regarding Pretreatment With Dual Antiplatelet Therapy for Patients With Non–ST Elevation Myocardial Infarction

J. Spertus, D. Cohen, J. Valle, 2016, Journal of the American Heart Association.

Predicting long‐term bleeding after percutaneous coronary intervention

J. Spertus, R. Bach, S. Arnold, 2017, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Early post-discharge bleeding and antiplatelet therapy discontinuation among acute myocardial infarction patients treated with percutaneous coronary intervention.

J. Messenger, D. Mark, G. Stone, 2014, Journal of the American College of Cardiology.

Cost-Effectiveness of Transcatheter Aortic Valve Replacement With a Self-Expanding Prosthesis Versus Surgical Aortic Valve Replacement.

D. Adams, C. Meduri, J. Popma, 2016, Journal of the American College of Cardiology.

Cost-Effectiveness of Percutaneous Coronary Interventions

A. Bakhai, D. Cohen, 2003 .

Cost-effectiveness of coronary interventions

D. Cohen, C. A. Sukin, D. Cohen, 1997, Heart.

Economics, health-related quality of life, and cost-effectiveness methods for the TACTICS (Treat Angina With Aggrastat [tirofiban]] and Determine Cost of Therapy with Invasive or Conservative Strategy)-TIMI 18 trial.

C. Cannon, H. Krumholz, J. Spertus, 1999, The American journal of cardiology.

Relationship between stent type and quality of life after percutaneous coronary intervention for acute myocardial infarction.

J. Spertus, D. Cohen, A. Chhatriwalla, 2015, American heart journal.

E. Mahoney, J. Stolker, J. Yadav, 2022 .

E. Mahoney, D. Cohen, D. Safley, 2022 .

A trial comparing rheolytic thrombectomy with intracoronary urokinase for coronary and vein graft thrombus (the Vein Graft AngioJet Study [VeGAS 2]).

Samin K. Sharma, D. Baim, A. Lansky, 2002, The American journal of cardiology.

Quality of life after balloon angioplasty or stenting for acute myocardial infarction. One-year results from the Stent-PAMI trial.

G. Stone, C. Grines, M. Morice, 2001, Journal of the American College of Cardiology.

The impact of optimal stenting techniques on cardiac catheterization laboratory resource utilization and costs.

D. Baim, D. Cohen, K. Ho, 1997, The American journal of cardiology.

Economic outcomes of percutaneous coronary intervention with drug‐eluting stents versus bypass surgery for patients with left main or three‐vessel coronary artery disease: One‐year results from the SYNTAX trial

Duane Pinto, P. Serruys, F. Mohr, 2012, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Clinical and Economic Outcomes of Liberal Versus Selective Drug-Eluting Stent Use: Insights From Temporal Analysis of the Multicenter Evaluation of Drug Eluting Stents and Ischemic Events (EVENT) Registry

M. Pencina, E. Mahoney, N. Kleiman, 2011, Circulation.

A strategy to offset the extra cost of sirolimus-eluting stent in patients undergoing intervention for acute myocardial infarction.

R. Ferrari, M. Valgimigli, D. Cohen, 2008, International journal of cardiology.

Clinical and economic effects of coronary restenosis after percutaneous coronary intervention in a managed care population.

D. Cohen, M. Clark, A. Bakhai, 2005, Managed care.

Impact of a practice guideline for patients with atrial fibrillation on medical resource utilization and costs.

M. Josephson, P. Zimetbaum, D. Cohen, 2003, The American journal of cardiology.

ECONOMIC IMPLICATIONS OF THE USE OF DIRECT THROMBIN INHIBITORS IN PERCUTANEOUS CORONARY INTERVENTION

D. Cohen, D. Cohen, 2005 .

Economics of elective coronary revascularization. Comparison of costs and charges for conventional angioplasty, directional atherectomy, stenting and bypass surgery.

M. Weinstein, D. Baim, D. Cohen, 1993, Journal of the American College of Cardiology.

Costs and effects of stent implantation versus balloon angioplasty

P. Serruys, B. Hout, D. Cohen, 1998 .

Cost-Effectiveness of Percutaneous Coronary Intervention With Drug Eluting Stents Versus Bypass Surgery for Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease: Results From the FREEDOM Trial

Lynn A. Sleeper, David J. Cohen, Valentin Fuster, 2013, Circulation.

Dual-Antiplatelet Therapy Cessation and Cardiovascular Risk in Relation to Age

T. Henry, D. Cohen, P. Steg, 2022 .

Pivotal Clinical Study to Evaluate the Safety and Effectiveness of the MANTA Percutaneous Vascular Closure Device.

M. Dake, W. O’Neill, D. Wood, 2019, Circulation. Cardiovascular interventions.

Adequacy of intracoronary versus intravenous adenosine-induced maximal coronary hyperemia for fractional flow reserve measurements.

A. Jeremias, S. Filardo, R. Whitbourn, 2000, American heart journal.

Comparison of effects of bare metal versus drug-eluting stent implantation on biomarker levels following percutaneous coronary intervention for non-ST-elevation acute coronary syndrome.

A. Kirtane, D. Morrow, S. Murphy, 2006, The American journal of cardiology.

Cost-Effectiveness of Edoxaban vs. Warfarin in Patients with Atrial Fibrillation Based on Results of the ENGAGE AF - TIMI 48 Trial: Taiwanese Perspective.

R. Giugliano, D. Cohen, E. Magnuson, 2017, Value in health regional issues.

L. Goldstein, T. Brott, G. Howard, 2011, Journal of the American College of Cardiology.

The Challenges of Success: Maintaining Access to High Quality PCI in the Face of Declining Procedural Volumes

R. Yeh, D. Cohen, S. Baron, 2014 .

Patient Characteristics Associated With Antianginal Medication Escalation and De-Escalation Following Chronic Total Occlusion Percutaneous Coronary Intervention.

J. Spertus, J. Moses, D. Cohen, 2019, Circulation. Cardiovascular quality and outcomes.

Impact of subintimal plaque modification procedures on health status after unsuccessful chronic total occlusion angioplasty

J. Spertus, J. Moses, D. Cohen, 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Quality of Life After Surgery or DES in Patients With 3-Vessel or Left Main Disease.

P. Serruys, M. Morice, D. Cohen, 2017, Journal of the American College of Cardiology.

Frequency, Predictors, and Consequences of Crossing Over to Revascularization Within 12 Months of Randomization to Optimal Medical Therapy in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial

Daniel S Berman, Mihaela Aslan, Paul Kolm, 2013, Circulation. Cardiovascular quality and outcomes.

The impact of dyspnea on health-related quality of life in patients with coronary artery disease: results from the PREMIER registry.

J. Spertus, S. Arnold, Lan Xiao, 2009, American heart journal.

Randomized, multicenter trial comparing sternotomy closure with rigid plate fixation to wire cerclage

D. Cohen, V. Thourani, K. Allen, 2017, The Journal of thoracic and cardiovascular surgery.

Coronary artery stenting in the aged.

D. Baim, J. Popma, D. Cohen, 2001, Journal of the American College of Cardiology.

Cost-effectiveness of oral antiplatelet agents—current and future perspectives

S. Arnold, D. Cohen, E. Magnuson, 2011, Nature Reviews Cardiology.

Cost effectiveness of paclitaxel-eluting stents for patients undergoing percutaneous coronary revascularization: results from the TAXUS-IV Trial.

G. Stone, S. Ellis, T. Lavelle, 2006, Journal of the American College of Cardiology.

When is better not good enough?: Insights from the COURAGE economic study.

A. Kirtane, D. Cohen, D. Cohen, 2008, Circulation. Cardiovascular quality and outcomes.

Correlation of patient-reported symptom outcomes and treadmill test outcomes after treatment for aortoiliac claudication.

J. Massaro, E. Mohler, J. Regensteiner, 2013, Journal of vascular and interventional radiology : JVIR.

Trial of everolimus-eluting stents or bypass surgery for coronary disease.

A. Yeung, M. Jeong, K. Seung, 2015, The New England journal of medicine.

Quality of life after PCI vs CABG among patients with diabetes and multivessel coronary artery disease: a randomized clinical trial.

V. Fuster, J. Spertus, M. Farkouh, 2013, JAMA.

Costs and Cost-Effectiveness of Carotid Stenting Versus Endarterectomy for Patients at Standard Surgical Risk: Results From the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST)

W. Gray, T. Brott, Jenifer Voeks, 2012, Stroke.

, Versus Stenting Trial ( CREST ) Standard Surgical Risk : Results From the Carotid Revascularization Endarterectomy Costs and Cost-Effectiveness of Carotid Stenting Versus Endarterectomy for Patients at

W. Gray, T. Brott, Jenifer Voeks, 2012 .

Comparison of Clinical Interpretation With Visual Assessment and Quantitative Coronary Angiography in Patients Undergoing Percutaneous Coronary Intervention in Contemporary Practice: The Assessing Angiography (A2) Project

M. Walsh, J. Elmore, W. Weaver, 2013, Circulation.

Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study.

J. Massaro, E. Mohler, J. Regensteiner, 2015, Journal of the American College of Cardiology.

Hospital Practice of Direct‐Home Discharge and 30‐Day Readmission After Transcatheter Aortic Valve Replacement in the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy (STS/ACC TVT) Registry

J. Rumsfeld, J. Hochman, D. Cohen, 2017, Journal of the American Heart Association.

Long-Term Clinical Outcomes After Unprotected Left Main Trunk Percutaneous Revascularization in 279 Patients

Seung‐Jung Park, S. Ellis, M. Nobuyoshi, 2001, Circulation.

Technical feasibility , safety , and clinical outcome of stenting of unprotected left main coronary artery bifurcation narrowing

R. Califf, E. Topol, H. Dauerman, 2022 .

Supervised Exercise Versus Primary Stenting for Claudication Resulting From Aortoiliac Peripheral Artery Disease: Six-Month Outcomes From the Claudication Exercise Versus Endoluminal Revascularization (CLEVER) Study

J. Ehrman, J. Massaro, E. Mohler, 2012, Circulation.

De-escalation of antianginal medications after successful chronic total occlusion percutaneous coronary intervention: Frequency and relationship with health status.

J. Spertus, J. Moses, S. Arnold, 2019, American heart journal.

W. Desmet, A. Lincoff, J. Bittl, 2006 .

Comparison of outcomes using sirolimus-eluting stenting in diabetic versus nondiabetic patients with comparison of insulin versus non-insulin therapy in the diabetic patients.

Brett G. Sylvia, A. Jeremias, A. Kirtane, 2007, The American journal of cardiology.

A blinded, randomized, placebo-controlled trial of percutaneous laser myocardial revascularization to improve angina symptoms in patients with severe coronary disease.

R. Hendel, R. Bonow, J. Moses, 2005, Journal of the American College of Cardiology.

Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial.

R. D'Agostino, M. Jaff, W. Henrich, 2006, American heart journal.

Reply: Cost-Effectiveness of Long-Term Ticagrelor in Patients With Prior Myocardial Infarction: Analysis by Subgroups.

Marc P. Bonaca, Deepak L. Bhatt, M. Sabatine, 2018, Journal of the American College of Cardiology.

Development of systems of care for ST-elevation myocardial infarction patients: evaluation and outcomes.

E. Ohman, E. Peterson, D. Magid, 2007, Circulation.

Readmission for Acute Decompensated Heart Failure among Patients Successfully Treated with Transcatheter Aortic Valve Replacement: A PARTNER-1 Substudy

L. Svensson, M. Leon, P. Douglas, 2018 .

The PARTNER 3 Bicuspid Registry for Transcatheter Aortic Valve Replacement in Low-Surgical-Risk Patients.

Jeroen J. Bax, J. Leipsic, W. O’Neill, 2022, JACC. Cardiovascular interventions.

Cost-effectiveness of everolimus- versus paclitaxel-eluting stents for patients undergoing percutaneous coronary revascularization (from the SPIRIT-IV Trial).

G. Stone, D. Cohen, M. Reynolds, 2012, The American journal of cardiology.

Using big data from health records from four countries to evaluate chronic disease outcomes: a study in 114 364 survivors of myocardial infarction

Nicholas Moore, Harry Hemingway, Spiros C. Denaxas, 2016, European heart journal. Quality of care & clinical outcomes.

Do Differences in Repeat Revascularization Explain the Antianginal Benefits of Bypass Surgery Versus Percutaneous Coronary Intervention?: Implications for Future Treatment Comparisons

P. Serruys, F. Mohr, S. Arnold, 2012, Circulation. Cardiovascular quality and outcomes.

Conducting economic evaluations alongside multinational clinical trials: toward a research consensus.

Andrew R Willan, Anastasios A Tsiatis, Ameet Bakhai, 2005, American heart journal.

Impact of COPD on Outcomes After MitraClip for Secondary Mitral Regurgitation: The COAPT Trial.

M. Mack, G. Stone, W. Abraham, 2020, JACC. Cardiovascular interventions.

Cost-Effectiveness Analysis of Hypertension Guidelines in South Africa: Absolute Risk Versus Blood Pressure Level

Milton C. Weinstein, Krisela Steyn, Lionel H. Opie, 2005, Circulation.

Association Between Diastolic Dysfunction and Health Status Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement.

J. Spertus, S. Arnold, D. Cohen, 2019, JACC. Cardiovascular interventions.

Evolution and Prognostic Impact of Cardiac Damage After Aortic Valve Replacement.

Jeroen J. Bax, T. Nazif, P. Pibarot, 2022, Journal of the American College of Cardiology.

Prognostic Implications of Creatine Kinase-MB Elevation After Percutaneous Coronary Intervention: Results From the Evaluation of Drug-Eluting Stents and Ischemic Events (EVENT) Registry

M. Pencina, N. Kleiman, D. Cohen, 2011, Circulation. Cardiovascular interventions.

Association of Patient-Reported Health Status With Long-Term Mortality After Transcatheter Aortic Valve Replacement: Report From the STS/ACC TVT Registry

Sean M. O'Brien, M. Mack, J. Spertus, 2015, Circulation. Cardiovascular interventions.

Rationale and design of the ATTRACT Study: a multicenter randomized trial to evaluate pharmacomechanical catheter-directed thrombolysis for the prevention of postthrombotic syndrome in patients with proximal deep vein thrombosis.

S. Goldhaber, M. Jaff, D. Cohen, 2013, American heart journal.

Cost-Effectiveness of Coronary Stenting and Abciximab for Patients With Acute Myocardial Infarction: Results From the CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) Trial

J. J. Griffin, G. Stone, C. Grines, 2003, Circulation.

Use of fractional myocardial flow reserve to assess the functional significance of intermediate coronary stenoses.

A. Jeremias, A. Yeung, P. Yock, 2000, The American journal of cardiology.

Five-Year Clinical and Quality of Life Outcomes From the CoreValve US Pivotal Extreme Risk Trial

G. Deeb, N. Kleiman, S. Arnold, 2021, Circulation. Cardiovascular interventions.

Predicting Quality of Life at 1 Year After Transcatheter Aortic Valve Replacement in a Real-World Population

F. Edwards, S. Arnold, D. Cohen, 2018, Circulation. Cardiovascular quality and outcomes.

Temporal Trends in Quality of Life Outcomes After Transapical Transcatheter Aortic Valve Replacement: A Placement of AoRTic TraNscathetER Valve (PARTNER) Trial Substudy

A. Kirtane, M. Leon, S. Arnold, 2015, Circulation. Cardiovascular quality and outcomes.

Immediate post-procedural functional assessment of percutaneous coronary intervention: current evidence and future directions.

D. Cohen, W. Wijns, Yundai Chen, 2021, European heart journal.

Temporal trends in the use of early cardiac catheterization in patients with non-ST-segment elevation acute coronary syndromes (results from CRUSADE).

Deepak L. Bhatt, L. Newby, C. Cannon, 2006, The American journal of cardiology.

Dual Antiplatelet Therapy Cessation and Adverse Events After Drug-Eluting Stent Implantation in Patients at High Risk for Atherothrombosis (from the PARIS Registry).

S. Pocock, T. Henry, M. Krucoff, 2018, The American journal of cardiology.

Effect ofMedication Copayment Vouchers on P 2 Y 12 Inhibitor Use andMajor Adverse Cardiovascular Events Among Patients WithMyocardial Infarction The ARTEMIS Randomized Clinical Trial

K. Anstrom, C. Cannon, T. Henry, 2018 .

Selecting Antiplatelet Therapy at the Time of Percutaneous Intervention for an Acute Coronary Syndrome: Weighing the Benefits and Risks of Prasugrel Versus Clopidogrel

J. Spertus, D. Cohen, Philip G. Jones, 2013, Circulation. Cardiovascular quality and outcomes.

In-hospital outcomes and cost comparison of femoropopliteal reopening strategies.

E. Mahoney, K. Allen, J. House, 2011, Cardiovascular revascularization medicine : including molecular interventions.

Transcatheter Mitral Valve Therapy in the United States: A Report From the STS-ACC TVT Registry.

J. Carroll, J. Bavaria, J. Squiers, 2021, Journal of the American College of Cardiology.

Bleeding complications after surgical aortic valve replacement compared with transcatheter aortic valve replacement: insights from the PARTNER I Trial (Placement of Aortic Transcatheter Valve).

M. Mack, A. Kirtane, L. Svensson, 2014, Journal of the American College of Cardiology.

Troponin criteria for myocardial infarction after percutaneous coronary intervention.

M. Pencina, V. Novack, N. Kleiman, 2012, Archives of internal medicine.

Quality-of-Life After Everolimus-Eluting Stents or Bypass Surgery for Left-Main Disease: Results From the EXCEL Trial.

P. Serruys, G. Stone, D. Kandzari, 2017, Journal of the American College of Cardiology.

Quality of Life after Everolimus-Eluting Stents or Bypass Surgery for Treatment of Left Main Disease

P. Serruys, G. Stone, D. Kandzari, 2017 .

Beyond Restenosis: Five-Year Clinical Outcomes From Second-Generation Coronary Stent Trials

D. Baim, J. Massaro, D. Cutlip, 2004, Circulation.

Socioeconomic and Geographic Characteristics of Hospitals Establishing Transcatheter Aortic Valve Replacement Programs, 2012–2018

J. Bavaria, J. Giri, N. Desai, 2021, Circulation. Cardiovascular Quality and Outcomes.

Association between thrombolysis in myocardial infarction myocardial perfusion grade, biomarkers, and clinical outcomes among patients with moderate- to high-risk acute coronary syndromes: observations from the randomized trial to evaluate the relative PROTECTion against post-PCI microvascular dysfu

E. Braunwald, P. Stone, A. Kirtane, 2006, American heart journal.

Relationship of creatine kinase-myocardial band release to Thrombolysis in Myocardial Infarction perfusion grade after intracoronary stent placement: an ESPRIT substudy.

S. Murphy, J. Tcheng, D. Cohen, 2002, American heart journal.

External Validation of the FREEDOM Score for Individualized Decision Making Between CABG and PCI.

David M. Kent, D. van Klaveren, E. Steyerberg, 2022, Journal of the American College of Cardiology.

Cost-effectiveness of clopidogrel plus aspirin versus aspirin alone for secondary prevention of cardiovascular events: results from the CHARISMA trial.

Deepak L. Bhatt, E. Topol, Jersey Chen, 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Deep Learning Electrocardiographic Analysis for Detection of Left-Sided Valvular Heart Disease.

Victor A. Rodriguez, G. Tison, A. Einstein, 2022, Journal of the American College of Cardiology.

Statistical primer: a cost-effectiveness analysis.

D. Cohen, R. Osnabrugge, C. Antonides, 2018, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Cost-effectiveness of transcatheter valvular interventions: economic challenges.

A Pieter Kappetein, David J Cohen, D. Cohen, 2013, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Variation in Antithrombotic Therapy and Clinical Outcomes in Patients With Preexisting Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement

J. Piccini, M. Mack, J. Rumsfeld, 2021, Circulation. Cardiovascular interventions.

Patient Recovery following Transcarotid or Transthoracic Transcatheter Aortic Valve Replacement

D. Cohen, K. Allen, A. Chhatriwalla, 2021 .

Prognostic implications of baseline 6‐min walk test performance in intermediate risk patients undergoing transcatheter aortic valve replacement

M. Mack, D. Wood, M. Leon, 2020, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Quality of Life after Everolimus-Eluting Stents or Bypass Surgery for Treatment of Left Main Disease after

P. Serruys, G. Stone, D. Kandzari, 2017 .

Health Status after Transcatheter vs. Surgical Aortic Valve Replacement in Low-Risk Patients with Aortic Stenosis.

M. Mack, M. Leon, S. Kapadia, 2019, Journal of the American College of Cardiology.

Hospital Variation in the Utilization of Short-Term Nondurable Mechanical Circulatory Support in Myocardial Infarction Complicated by Cardiogenic Shock

R. Yeh, J. Popma, D. Cohen, 2019, Circulation. Cardiovascular interventions.

Valve-in-valve TAVR using the SAPIEN 3 transcatheter heart valve: still plagued by patient-prosthesis mismatch.

T. Feldman, D. Cohen, J. Saxon, 2018, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Long-term Efficacy of Bivalirudin and Provisional Glycoprotein IIb/IIIa Blockade vs Heparin and Planned Glycoprotein IIb/IIIa Blockade During Percutaneous Coronary Revascularization

E. Topol, W. Desmet, A. Lincoff, 2004 .

Mortality Following Cardiovascular and Bleeding Events Occurring Beyond 1 Year After Coronary Stenting: A Secondary Analysis of the Dual Antiplatelet Therapy (DAPT) Study

R. D'Agostino, C. Cannon, J. Massaro, 2017, JAMA cardiology.

Comparing Cost-Utility Analyses in Cardiovascular Medicine

W. Winkelmayer, D. Cohen, P. Neumann, 2003 .

Impact of Transcatheter Aortic Valve Durability on Life Expectancy in Low-Risk Patients With Severe Aortic Stenosis

J. Webb, D. Cohen, H. Wijeysundera, 2020, Circulation.

Factors Associated With and Outcomes of Aborted Procedures During Elective Transcatheter Aortic Valve Replacement.

A. Kirtane, N. Desai, A. Kosinski, 2019, JACC. Cardiovascular interventions.

The CLEVER ( Claudication : Exercise Vs . Endoluminal Revascularization ) Study : Rationale and Methods

J. Ricotta, E. Mohler, J. Regensteiner, 2008 .

Impact of drug eluting stent length on outcomes of percutaneous coronary intervention (from the EVENT registry).

M. Pencina, R. Bach, N. Kleiman, 2012, The American journal of cardiology.

Drug-Coated Balloon Versus Standard Percutaneous Transluminal Angioplasty for the Treatment of Superficial Femoral and Popliteal Peripheral Artery Disease

D. Scheinert, M. Jaff, P. Krishnan, 2015, Circulation.

Evaluation of outpatient initiation of antiarrhythmic drug therapy in patients reverting to sinus rhythm after an episode of atrial fibrillation.

M. Josephson, L. Epstein, P. Zimetbaum, 1999, The American journal of cardiology.

Mechanical debulking versus balloon angioplasty for the treatment of true bifurcation lesions.

H. Dauerman, D. Baim, D. Cohen, 1998, Journal of the American College of Cardiology.

Cost-Effectiveness of Transcatheter Mitral Valve Repair versus Medical Therapy in Patients with Heart Failure and Secondary Mitral Regurgitation: Results from the COAPT Trial.

M. Mack, G. Stone, B. Whisenant, 2019, Circulation.

Incidence, Management, and Associated Clinical Outcomes of New-Onset Atrial Fibrillation Following Transcatheter Aortic Valve Replacement: An Analysis From the STS/ACC TVT Registry.

J. Piccini, A. Kirtane, E. Peterson, 2018, JACC. Cardiovascular interventions.

The influence of diabetes mellitus on the practice and outcomes of percutaneous coronary intervention in the community: a report from the HCA database.

M. Mack, D. Cohen, L. Tarkington, 2003, The Journal of invasive cardiology.

Incidence and clinical outcome of minor surgery in the year after drug-eluting stent implantation: results from the Evaluation of Drug-Eluting Stents and Ischemic Events Registry.

M. Pencina, Subhash Banerjee, E. Brilakis, 2011, American heart journal.

Fractional Flow Reserve Compared With Intravascular Ultrasound Guidance for Optimizing Stent Deployment

A. Jeremias, A. Yeung, P. Fitzgerald, 2001, Circulation.

Individualizing Revascularization Strategy for Diabetic Patients With Multivessel Coronary Disease.

V. Fuster, J. Spertus, M. Farkouh, 2019, Journal of the American College of Cardiology.

Reply: Cost-Effectiveness of Long-Term Ticagrelor in Patients With Prior Myocardial Infarction: Analysis by Subgroups.

Marc P. Bonaca, Deepak L. Bhatt, M. Sabatine, 2018, Journal of the American College of Cardiology.

Cost-Effectiveness of Percutaneous Coronary Intervention Versus Bypass Surgery for Patients With Left Main Disease: Results From the EXCEL Trial

P. Serruys, G. Stone, J. Sabik, 2022, Circulation. Cardiovascular interventions.

Current clinical characteristics and economic impact of subacute stent thrombosis.

D. Cohen, D. Pinto, M. Rinaldi, 2002, The Journal of invasive cardiology.

Incidence, Predictors, and Outcomes of Patients Discharged Home Versus Other Medical Facility After Transcatheter or Surgical Aortic Valve Replacement

M. Leon, S. Arnold, D. Cohen, 2021, Structural Heart.

The Future REvascularization Evaluation in patients with Diabetes mellitus: optimal management of Multivessel disease (FREEDOM) trial: clinical and angiographic profile at study entry.

V. Fuster, M. Domanski, G. Dangas, 2012, American heart journal.

Effects of Ranolazine on Disease-Specific Health Status and Quality of Life Among Patients With Acute Coronary Syndromes: Results from the MERLIN-TIMI 36 Randomized Trial

E. Braunwald, D. Morrow, B. Scirica, 2008, Circulation. Cardiovascular quality and outcomes.

E. Mahoney, J. Stolker, J. Yadav, 2010, JACC. Cardiovascular interventions.

Comparison of Physician Visual Assessment With Quantitative Coronary Angiography in Assessment of Stenosis Severity in China

Harlan M Krumholz, Lixin Jiang, Jing Li, 2018, JAMA internal medicine.

Benefits and Risks of Extended Dual Antiplatelet Therapy After Everolimus-Eluting Stents.

M. Krucoff, S. Windecker, J. Massaro, 2016, JACC. Cardiovascular interventions.

Cost-effectiveness of percutaneous coronary intervention versus bypass surgery from a Dutch perspective

D. van Klaveren, E. Steyerberg, P. Serruys, 2015, Heart.

Prevalence and Outcomes of Isolated Tricuspid Valve Surgery Among Medicare Beneficiaries.

R. Yeh, J. Popma, D. Cohen, 2019, American Journal of Cardiology.

Transcatheter Aortic Valve Replacement in Low-Population Density Areas

C. O'connor, J. Messenger, J. Carroll, 2020, Circulation. Cardiovascular quality and outcomes.

The limits of cost-effectiveness analysis.

William S Weintraub, David J Cohen, W. Weintraub, 2009, Circulation. Cardiovascular quality and outcomes.

Cardiovascular Perspectives The Limits of Cost-Effectiveness Analysis

W. Weintraub, D. Cohen, D. Cohen, 2009 .

STS-ACC TVT Registry of Transcatheter Aortic Valve Replacement.

J. Carroll, M. Mack, J. Bavaria, 2020, The Annals of thoracic surgery.

Effect of thoracic epidural analgesia on clinical outcomes following transapical transcatheter aortic valve implantation

P. Pibarot, L. Nombela‐Franco, J. Rodés‐Cabau, 2012, Heart.

Cost-Effectiveness of Pharmacomechanical Catheter-Directed Thrombolysis Versus Standard Anticoagulation in Patients With Proximal Deep Vein Thrombosis: Results From the ATTRACT Trial.

S. Goldhaber, M. Jaff, D. Cohen, 2019, Circulation. Cardiovascular quality and outcomes.

Vision and Creation of the American Heart Association Pharmaceutical Roundtable Outcomes Research Centers

A. Go, J. Spertus, E. Peterson, 2009, Circulation. Cardiovascular quality and outcomes.

The association between blood pressure and mortality in patients with heart failure.

David J Cohen, Jersey Chen, D. Cohen, 2006, American heart journal.

3-Year Outcomes of Transcatheter Mitral Valve Repair in Patients With Heart Failure.

M. Mack, G. Stone, N. Weissman, 2021, Journal of the American College of Cardiology.

Hospitalizations and Mortality in Patients With Secondary Mitral Regurgitation and Heart Failure: The COAPT Trial.

G. Stone, F. Asch, W. Abraham, 2022, Journal of the American College of Cardiology.

Causes of late mortality with dual antiplatelet therapy after coronary stents.

S. Windecker, J. Massaro, L. Mauri, 2015, European heart journal.

Survival Benefit With Drug-Eluting Stents in Observational Studies: Fact or Artifact?

P. Chan, N. Kleiman, D. Cohen, 2011, Circulation. Cardiovascular quality and outcomes.

Vascular closure devices: the second decade.

H. Dauerman, R. Applegate, D. Cohen, 2007, Journal of the American College of Cardiology.

Outcome of patients with acute myocardial infarction who are ineligible for primary angioplasty trials

H. Dauerman, D. Baim, D. Cohen, 2000, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Contemporary risk model for inhospital major bleeding for patients with acute myocardial infarction: The acute coronary treatment and intervention outcomes network (ACTION) registry®–Get With The Guidelines (GWTG)®

J. Spertus, R. McNamara, N. Desai, 2017, American heart journal.

Frequency, predictors, and outcomes of drug-eluting stent utilization in patients with high-risk non-ST-segment elevation acute coronary syndromes.

W. Gibler, E. Ohman, Sidney C. Smith, 2005, The American journal of cardiology.

Drug eluting stents for ST-elevation myocardial infarction: risk and benefit

D. Cutlip, Duane S Pinto, J. Ryan, 2007, Journal of Thrombosis and Thrombolysis.

Cost-Effectiveness of Percutaneous Coronary Intervention with Drug-Eluting Stents vs. Bypass Surgery for Patients with 3-Vessel or Left Main Coronary Artery Disease: Final Results from the SYNTAX Trial

P. Serruys, F. Mohr, M. Morice, 2014 .

Healthcare Resource Utilization and Costs Associated with Recurrent Episodes of Atrial Fibrillation: The FRACTAL Registry

P. Zimetbaum, D. Cohen, M. Reynolds, 2007, Journal of cardiovascular electrophysiology.

Abstract 16534: Cost-Effectiveness of Edoxaban vs. Warfarin in Patients With Atrial Fibrillation: Results From the ENGAGE AF - TIMI 48 Economic Study

E. Antman, E. Magnuson, C. Ruff, 2014 .

Long‐term clinical and quality of life outcomes after stenting of femoropopliteal artery stenosis: 3‐year results from the STROLL study

W. Gray, M. Jaff, D. Cohen, 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Differential outcomes after sirolimus-eluting stent implantation: comparing on-label versus off-label patients in the ‘real world’

Brett G. Sylvia, A. Jeremias, A. Kirtane, 2008, Coronary artery disease.

Abstract 15573: In-Hospital Switching of ADP Receptor Inhibitors in Myocardial Infarction Patients Treated with Percutaneous Coronary Intervention: Insights from the TRANSLATE-ACS Study

K. Anstrom, J. Messenger, A. Bagai, 2012 .

Feasibility and implications of an early discharge strategy after percutaneous intervention with abciximab in acute myocardial infarction (the CADILLAC Trial)

J. J. Griffin, J. Carroll, G. Stone, 2003 .

Impact of routine angiographic follow-up on the clinical benefits of paclitaxel-eluting stents: results from the TAXUS-IV trial.

G. Stone, S. Ellis, R. Mehran, 2006, Journal of the American College of Cardiology.

Health Status Changes and Outcomes in Patients with Heart Failure and Mitral Regurgitation: From COAPT.

M. Mack, G. Stone, W. Abraham, 2020, Journal of the American College of Cardiology.

No "i" in Heart Team: incentivizing multidisciplinary care in cardiovascular medicine.

B. Nallamothu, D. Cohen, 2012, Circulation. Cardiovascular quality and outcomes.

Impact of Clinical Syndrome Acuity on the Differential Response to 2 Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Coronary Stenting: The TARGET Trial*

E. Topol, G. Stone, C. Grines, 2002, Circulation.

Durability of Treatment Effect Using a Drug-Coated Balloon for Femoropopliteal Lesions: 24-Month Results of IN.PACT SFA.

Hong Wang, D. Scheinert, M. Jaff, 2015, Journal of the American College of Cardiology.

Impact of proton pump inhibitors and dual antiplatelet therapy cessation on outcomes following percutaneous coronary intervention: Results From the PARIS Registry

S. Pocock, T. Henry, G. Dangas, 2016, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Clinical and economic outcomes among elderly myocardial infarction survivors in the United States.

S. Johansson, D. Cohen, P. Hunt, 2016, Cardiovascular therapeutics.

Percutaneous Coronary Intervention: Finally Mature Enough.

S. Rinfret, S. Baron, D. Cohen, 2015, Journal of the American College of Cardiology.

Effect of clopidogrel pretreatment on ischemic complications of percutaneous coronary intervention among bivalirudin-treated patients (from the EVENT registry).

M. Pencina, N. Kleiman, D. Cohen, 2011, The American journal of cardiology.

Cost-effectiveness of prasugrel in a US managed care population

D. Cohen, J. Bae, J. Mauskopf, 2012, Journal of medical economics.

Does stenting save lives? Understanding the strengths and limitations of meta-analysis.

D. Cohen, A. Shroff, D. Cohen, 2004, American heart journal.

Association between health status and long‐term mortality after percutaneous revascularization of peripheral artery disease

J. Spertus, D. Cohen, D. Safley, 2016, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

P he Frequency and Incremental Cost of Major omplications Among Medicare Beneficiaries eceiving Implantable Cardioverter-Defibrillators

R. Reynolds, D. Cohen, E. Becker, 2006 .

Versus Blood Pressure Level Cost-Effectiveness Analysis of Hypertension Guidelines in South Africa : Absolute Risk

M. Weinstein, L. Opie, D. Cohen, 2005 .

Cost-effectiveness of folic acid therapy for primary prevention of stroke in patients with hypertension

D. Cohen, Gordon Liu, X. Qin, 2022, BMC Medicine.

Surgical Versus Percutaneous Femoral Access for Delivery of Large-Bore Cardiovascular Devices (from the PARTNER Trial).

M. Mack, F. Welt, M. Leon, 2016, The American journal of cardiology.

V. Fuster, L. Sleeper, M. Farkouh, 2013, Circulation.

Association of a P2Y12 Inhibitor Copayment Reduction Intervention With Persistence and Adherence With Other Secondary Prevention Medications: A Post Hoc Analysis of the ARTEMIS Cluster-Randomized Clinical Trial.

K. Anstrom, G. Fonarow, C. Cannon, 2019, JAMA cardiology.

Willingness To Pay To Eliminate the Risk of Restenosis Following Percutaneous Coronary Intervention: A Contingent Valuation